Stock

Scores

Our own judgement on a company, computed from filings and datasets we maintain here rather than taken from a feed — with the arithmetic shown, so you can disagree with it.

Flags
what we computewhat you can get elsewhere too
TickerCompanyOur balanceFundamentalsFlagsIPOMarket capLast3-monthSince IPOAnalyst indexConsensusTarget
ASPEAspen Neuroscience, Inc.Too new to judge—Coverage still thin, Large daily move2026-10-30$366M$12.39—-12.0%———
BBTXBambusa Therapeutics, Inc.Too new to judge—Coverage still thin2026-10-30$820M$15.55—+2.3%———
LYCALycia Therapeutics, Inc.Leans down -2
weak
revenue -54.9%
Coverage still thin, Shrinking revenue2026-10-23$1.8B$31.77—+54.5%———
CTYCity Therapeutics, Inc.Mixed +1
weak
revenue +388.2%
—2026-10-16$901M$18.35—+15.1%10.0Strong Buy (3)$37.33 +103%
ACCVAccelevation Holdings Corp.Leans up +2
medium
loss-making -0.1%
revenue +146.9%
heavily indebted
—2026-09-30$2.9B$11.09—-9.1%7.5Buy (8)$19.29 +74%
ADRXADARx Pharmaceuticals, Inc.Leans up +3
weak
pre-revenue
—2026-09-25$1.5B$14.16—-0.5%8.0Strong Buy (5)$34.25 +142%
ETRAElectra Therapeutics, Inc.Leans up +3
weak
—Fell, analysts held2026-09-18$555M$8.94—-44.8%9.2Strong Buy (6)$33.20 +271%
OIGOrion180 Insurance Group Inc.Leans up +3
medium
profitable 20.6%
revenue +38.3%
heavily indebted
—2026-09-18$1.1B$10.28—-0.9%6.7Buy (6)$15.08 +47%
ASBHAmerican Savings Bank, National AssociationMixed 0
weak
—2026-09-16$1.4B$20.33—+28.7%6.3Buy (4)$21.00 +3%
LYNXLyntris Inc.Up +6
strong
revenue +16.5%
heavily indebted
Fell on sound metrics, Upgrade, Improving confidence2026-08-19$1.6B$12.69—-39.0%10.0Strong Buy (7)$19.83 +56%
FOILLondian Wason New Energy Tech Inc.Mixed 0
weak
revenue +24.9%
—2026-08-12$1.1B$13.97-41.0%-23.6%———
BLSMBlossomHill Therapeutics, Inc.Leans up +3
weak
——2026-08-07$446M$14.41-14.4%-19.4%9.0Strong Buy (5)$35.40 +146%
LTGOLatigo Biotherapeutics, Inc.Mixed 0
weak
——2026-08-07$869M$13.24-32.1%-21.9%10.0Strong Buy (4)$52.25 +295%
BRVEBraveheart Bio, Inc.Leans up +3
weak
——2026-08-06$1.6B$19.27-29.1%+23.3%10.0Strong Buy (5)$45.50 +136%
ATTOAttovia Therapeutics, Inc.Leans up +2
weak
pre-revenue
revenue -100.0%
Shrinking revenue2026-08-05$691M$15.58-33.4%-12.3%8.0Strong Buy (5)$43.20 +177%
APMDApnimed, Inc.Leans up +2
weak
profitable 83.8%
revenue +380.1%
—2026-07-31$704M$17.25-48.0%+7.8%10.0Strong Buy (4)$50.33 +192%
JMKEJersey Mike's Subs Inc.Leans down -2
medium
loss-making -2.6%
revenue +10.9%
heavily indebted
Weakening confidence2026-07-30$6.2B$17.81-13.8%-16.4%6.8Buy (25)$26.00 +46%
REFReformation Inc.Mixed 0
weak
profitable 0.9%
revenue +15.7%
heavily indebted
—2026-07-30$1.1B$19.42+13.8%+6.9%7.8Strong Buy (9)$20.50 +6%
IMCIMC Rare Earths LtdMixed 0
weak
—2026-07-29$852M$7.50-4.6%+116.9%———
IONDIonic Digital Inc.Mixed 0
weak
loss-making -24.9%
revenue +22.5%
Large daily move2026-07-28$2.7B$58.00-10.2%—10.0Strong Buy (3)$92.67 +60%
CSQRCsquare, Inc.Mixed +1
weak
loss-making -21.8%
revenue +8.8%
heavily indebted
Fell, analysts held2026-07-16$2.8B$15.19-25.2%-25.8%7.5Buy (10)$27.90 +84%
QMLSQumulusAI, Inc.Leans down -3
medium
pre-revenue
revenue +62.5%
liquidity 0.8
Thin liquidity, Halved from offer2026-07-16$92M$2.12-61.5%—10.0Strong Buy (3)$10.33 +388%
STDNStandard Nuclear, Inc.Leans up +2
weak
pre-revenue
Fell, analysts held2026-07-16$1.7B$9.01-20.7%-31.5%8.3Strong Buy (9)$16.88 +87%
SKHYSK hynix Inc.Up +5
strong
profitable 85.6%
revenue +46.8%
heavily indebted
Improving confidence2026-07-10$663.0B$119.20-23.1%+2.6%7.7Strong Buy (15)$259.50 +118%
BSPBending Spoons S.p.A.Mixed -1
weak
profitable 6.1%
revenue +288.7%
liquidity 0.6
heavily indebted
Thin liquidity2026-07-01$27.0B$41.70+6.7%+51.6%5.8Buy (12)$47.67 +14%
ITGITG, Inc.Up +4
strong
profitable 1.1%
revenue +15.7%
heavily indebted
Fell on sound metrics, Profitable but deeply down, Large daily move, Weekly spike, Halved from offer2026-07-01$705M$6.18-54.2%-52.6%9.4Strong Buy (9)$11.33 +83%
LIMENeutron Holdings, Inc.Mixed +1
medium
profitable 23.4%
revenue +29.1%
heavily indebted
—2026-07-01$1.3B$20.17-46.1%+3.4%8.1Strong Buy (8)$33.14 +64%
SINDSinda Ltd.Leans up +3
weak
——2026-06-26$1.9B$11.18-29.1%-8.2%7.5Buy (6)$18.40 +65%
DPCDPC Holdings PLCMixed +1
weak
loss-making -31.4%
revenue +12.2%
heavily indebted
—2026-06-25$5.1B$34.18-33.4%+4.4%6.0Buy (5)$52.20 +53%
FCBMFirst Carolina Financial Services, Inc.Up +5
strong
profitable 15.3%
revenue +92.6%
heavily indebted
Upgrade2026-06-18$417M$13.07+5.7%+5.0%6.7Buy (3)$15.00 +15%
KARDKardigan, Inc.Leans up +3
weak
heavily indebted
—2026-06-18$1.3B$12.52-32.8%-20.9%9.4Strong Buy (9)$41.00 +227%
SPCXSpace Exploration Technologies Corp.Up +4
strong
loss-making -8.6%
revenue +33.2%
heavily indebted
Improving confidence2026-06-12$1.89T$138.43-4.9%+4.7%6.5Buy (40)$255.63 +85%
FRBTForbright, Inc.Leans up +3
medium
profitable 13.7%
revenue +30.2%
heavily indebted
—2026-06-11$951M$17.11-1.9%+2.5%6.7Buy (6)$23.25 +36%
EROCERock, Inc.Up +4
strong
loss-making -50.2%
revenue +42.5%
heavily indebted
Fell on sound metrics, Halved from offer2026-06-10$2.3B$7.25-51.7%-56.6%7.5Buy (8)$18.88 +160%
PBLSParabilis Medicines, Inc.Mixed +1
weak
pre-revenue
heavily indebted
—2026-06-10$3.6B$27.63-23.6%+35.8%10.0Strong Buy (7)$41.00 +48%
WHKWhiteHawk Minerals Corp.Mixed +1
medium
loss-making -117.9%
revenue +427.7%
heavily indebted
—2026-06-09$791M$25.01-0.5%+2.2%8.0Strong Buy (5)$32.40 +30%
INIOInnio N.V.Leans up +3
medium
profitable 2.7%
revenue +22.1%
heavily indebted
Lock-up expiry, Fell on sound metrics, Halved from offer2026-06-04$10.9B$12.81-48.2%-35.7%6.0Buy (10)$31.40 +145%
LFTOLiftoff Mobile, Inc.Mixed +1
medium
profitable 5.2%
revenue +32.1%
Lock-up expiry, Large daily move, Weekly spike, Monthly spike2026-06-04$4.1B$23.66+25.1%-17.7%6.9Buy (18)$30.38 +28%
QNTQuantinuum Inc.Leans up +3
medium
loss-making -106.4%
revenue +34.6%
heavily indebted
Lock-up expiry, Fell on sound metrics2026-06-04$9.4B$27.96-46.4%-51.4%8.9Strong Buy (14)$71.15 +154%
SSMRSunshine Silver Mining & Refining CompanyLeans up +3
medium
pre-revenue
revenue +421.8%
Lock-up expiry2026-06-04$1.9B$12.04-18.8%-19.7%6.7Buy (6)$19.08 +58%
AADXApplied Aerospace & Defense, Inc.Leans down -3
medium
loss-making -45.0%
revenue +51.2%
heavily indebted
Lock-up expiry, Downgrade, Halved from offer2026-06-03$1.4B$6.43-53.8%-51.8%6.9Buy (8)$17.75 +176%
CNXUConexeu Sciences Inc.Mixed -1
weak
—Lock-up expiry, Monthly spike, Halved from offer2026-05-21$67M$2.08-77.7%————
AMSSAMASS Brands, Inc.Down -6
weak
loss-making -78.6%
revenue -17.7%
liquidity 0.7
Lock-up expiry, Shrinking revenue, Thin liquidity, Value trap2026-05-20$3M$0.23-76.8%————
LCLNLincoln International, Inc.Mixed 0
medium
loss-making -9.5%
revenue +47.6%
heavily indebted
Lock-up expiry2026-05-20$2.8B$27.25+8.8%+35.9%3.6Buy (7)$28.36 +4%
BXDCBlackstone Digital Infrastructure Trust Inc.Mixed -1
weak
—Lock-up expiry2026-05-14$1.7B$16.37-17.9%-17.5%5.0Buy (11)$23.36 +43%
CBRSCerebras Systems Inc.Mixed +1
medium
loss-making -31.0%
revenue +75.7%
heavily indebted
Lock-up expiry, Fell on sound metrics, Large daily move, Weekly spike, Halved from offer2026-05-14$26.4B$86.96-56.9%-36.9%8.6Strong Buy (11)$210.18 +142%
EROKEagleRock Land, LLCMixed +1
medium
loss-making -79.7%
revenue +699.0%
Lock-up expiry2026-05-14$2.8B$20.29-17.5%+9.4%5.0Buy (6)$27.33 +35%
FRVOFervo Energy CompanyMixed +1
weak
pre-revenue
revenue -30.6%
heavily indebted
Lock-up expiry, Fell, analysts held, Shrinking revenue, Improving confidence, Weekly spike, Halved from offer2026-05-13$3.4B$11.14-36.4%-61.0%8.1Strong Buy (16)$29.47 +165%
GMRSGMR Solutions Inc.Mixed +1
medium
profitable 3.8%
revenue -4.0%
heavily indebted
Lock-up expiry, Fell on sound metrics2026-05-13$1.0B$10.01-16.6%-31.3%7.5Buy (8)$18.38 +84%
MOBIMobia Medical, Inc.Mixed -1
medium
loss-making -135.0%
revenue +104.8%
heavily indebted
Lock-up expiry, Monthly spike2026-05-08$439M$11.86+12.2%-21.0%8.8Strong Buy (4)$18.00 +52%
ODTXOdyssey Therapeutics, Inc.Leans down -2
medium
revenue -33.5%
heavily indebted
Lock-up expiry, Shrinking revenue2026-05-08$918M$18.34-8.2%+8.0%8.8Strong Buy (8)$34.67 +89%
HAWKHawkEye 360, Inc.Up +4
strong
loss-making -16.2%
revenue +162.6%
heavily indebted
Lock-up expiry, Fell on sound metrics, Improving confidence, Large daily move, Weekly spike, Monthly spike2026-05-07$1.8B$18.08-21.6%-35.5%8.6Strong Buy (11)$27.70 +53%
SUJASuja Life, Inc.Down -5
strong
loss-making -0.6%
revenue +26.1%
heavily indebted
Lock-up expiry, Downgrade, Weakening confidence, Large daily move, Weekly spike, Halved from offer2026-05-07$272M$6.35+5.9%-64.7%3.6Buy (7)$12.40 +95%
COAGHemab Therapeutics Holdings, Inc.Mixed 0
medium
—Lock-up expiry2026-05-01$1.9B$39.86-23.8%+90.7%9.3Strong Buy (7)$63.00 +58%
SPTXSeaport Therapeutics, Inc.Mixed +1
weak
—Lock-up expiry2026-05-01$1.1B$18.32-18.1%+3.3%8.3Strong Buy (9)$37.13 +103%
AVLNAvalyn Pharma Inc.Mixed 0
medium
heavily indebted
Lock-up expiry2026-04-30$1.3B$28.70-20.8%+47.7%8.0Strong Buy (5)$61.00 +113%
PSPershing Square Inc.Down -7
strong
loss-making -82.9%
revenue +64.7%
heavily indebted
Lock-up expiry, Weakening confidence, Sell majority, Below target2026-04-29$17.9B$36.84+13.5%-19.0%-1.5Hold (10)$43.56 +18%
XEX-Energy, Inc.Mixed +1
weak
loss-making -189.9%
revenue +12.2%
Lock-up expiry, Halved from offer2026-04-24$4.5B$9.70-45.9%-52.1%5.0Buy (11)$25.61 +164%
ELMTThe Elmet Group Co.Leans down -2
weak
loss-making -1.2%
revenue +5.9%
heavily indebted
Lock-up expiry2026-04-23$608M$19.50+3.8%+59.8%8.8Strong Buy (4)$29.00 +49%
NHPNational Healthcare Properties, Inc.Leans down -2
medium
loss-making -3.4%
revenue -3.2%
liquidity 0.4
heavily indebted
Lock-up expiry, Thin liquidity2026-04-22$1.1B$14.51-9.2%+24.1%5.0Buy (8)$19.57 +35%
YSWYYesway, Inc.Mixed 0
medium
profitable 2.3%
revenue +5.8%
heavily indebted
Lock-up expiry2026-04-22$1.6B$19.30-0.8%+27.4%5.6Buy (9)$29.63 +54%
ALMRAlamar Biosciences, Inc.Mixed 0
medium
loss-making -48.2%
revenue +195.2%
heavily indebted
Lock-up expiry2026-04-17$2.1B$28.68-4.1%+87.0%7.0Buy (5)$37.00 +29%
AVEXAEVEX Corp.Leans up +2
weak
loss-making -2.8%
revenue +10.4%
Lock-up expiry, Fell, analysts held, Large daily move, Weekly spike2026-04-17$1.6B$12.86-38.1%-29.3%7.5Buy (10)$25.44 +98%
KLRAKailera Therapeutics, Inc.Leans up +2
weak
—Lock-up expiry2026-04-17$1.7B$11.58-28.3%-22.3%9.3Strong Buy (7)$43.00 +271%
ARXSArxis, Inc.Mixed 0
medium
profitable 6.5%
revenue +115.5%
heavily indebted
Lock-up expiry2026-04-16$23.0B$51.52-7.5%+93.4%9.1Strong Buy (11)$66.50 +29%
MAIRMadison Air Solutions CorporationLeans up +3
medium
profitable 6.7%
revenue +34.1%
heavily indebted
Lock-up expiry, Improving confidence2026-04-16$14.1B$23.19-19.6%-11.1%8.5Strong Buy (10)$34.00 +47%
HMHHMH Holding Inc.Leans down -2
medium
loss-making -1.3%
revenue -2.6%
heavily indebted
Downgrade2026-04-01$542M$11.20-42.0%-2.1%7.9Strong Buy (7)$22.43 +100%
JANJanus Living, Inc.Mixed 0
medium
loss-making -2.0%
revenue +35.7%
liquidity 0.5
Thin liquidity2026-03-20$10.8B$31.67+4.6%+41.5%6.7Buy (15)$35.00 +11%
PAYPPayPay CorporationUp +5
strong
profitable 16.3%
revenue +25.9%
heavily indebted
—2026-03-12$9.7B$12.91-4.1%-13.1%7.7Strong Buy (13)$23.67 +83%
MMEDMiniMed Group, Inc.Mixed +1
weak
loss-making -10.3%
revenue +14.2%
—2026-03-06$5.1B$16.26-7.9%+1.7%7.2Buy (16)$25.33 +56%
GENBGenerate Biomedicines, Inc.Up +4
strong
pre-revenue
revenue +55.9%
heavily indebted
—2026-02-27$1.6B$10.37-23.1%-23.7%8.0Strong Buy (5)$26.25 +153%
AIDX20/20 Biolabs, Inc.Mixed -1
weak
loss-making -285.0%
revenue +16.7%
heavily indebted
—2026-02-19$3M$0.18-63.6%————
SHAZSharonAI Holdings Inc.Mixed +1
medium
pre-revenue
revenue +257.4%
heavily indebted
Large daily move2026-02-18$808M$20.54-70.7%—10.0Strong Buy (6)$105.00 +411%
APCARKO Petroleum Corp.Mixed 0
medium
profitable 0.7%
revenue -12.3%
heavily indebted
Shrinking revenue, Improving confidence2026-02-12$695M$12.95-25.0%-17.7%10.0Strong Buy (4)$21.25 +64%
AGBKAgi Inc.Up +6
strong
profitable 12.7%
revenue +34.7%
heavily indebted
Fell on sound metrics, Profitable but deeply down, Weekly spike2026-02-11$1.0B$5.34+3.0%-44.2%8.2Strong Buy (11)$10.44 +96%
MWHSOLV Energy, Inc.Mixed +1
medium
profitable 3.8%
revenue +34.8%
heavily indebted
—2026-02-11$5.6B$27.18-11.8%+4.1%8.6Strong Buy (11)$40.55 +49%
AGMBAgomAb Therapeutics NVUp +4
medium
—Fell, analysts held, Improving confidence, Halved from offer2026-02-06$313M$5.62-53.5%-65.0%7.9Strong Buy (7)$37.67 +570%
OFRMOnce Upon A Farm, PBCMixed 0
medium
loss-making -3.3%
Weakening confidence, Monthly spike, Halved from offer2026-02-06$408M$12.39-44.7%-45.3%3.3Buy (9)$12.50 +1%
SGPSpyGlass Pharma, Inc.Mixed +1
weak
——2026-02-06$1.1B$30.78+27.5%+87.1%9.2Strong Buy (6)$46.67 +52%
BOBSBob's Discount Furniture, Inc.Leans down -2
weak
profitable 5.7%
revenue +16.8%
liquidity 0.9
heavily indebted
Thin liquidity2026-02-05$2.7B$19.82+11.9%+8.3%6.9Buy (13)$23.15 +17%
EIKNEikon Therapeutics, Inc.Leans up +3
medium
heavily indebted
Fell, analysts held, Improving confidence, Halved from offer2026-02-05$324M$4.76-42.9%-68.0%5.7Buy (7)$24.33 +411%
FPSForgent Power Solutions, Inc.Mixed 0
medium
profitable 7.4%
revenue +88.5%
heavily indebted
—2026-02-05$6.7B$20.96-43.0%+3.3%8.1Strong Buy (13)$42.85 +104%
MANEVeradermics, IncorporatedMixed +1
weak
——2026-02-04$5.5B$124.39+19.8%+611.9%9.3Strong Buy (7)$187.33 +51%
PLYXPolaryx Therapeutics, Inc.Leans up +2
weak
—Improving confidence, Halved from offer2026-01-30$88M$1.51-15.7%—8.8Strong Buy (4)$7.50 +397%
LIFEEthos Technologies Inc.Leans up +2
medium
loss-making -16.2%
revenue +52.0%
—2026-01-29$2.2B$32.13-5.4%+122.7%7.8Strong Buy (9)$53.38 +66%
PICSPicS N.V.Up +5
strong
profitable 15.7%
revenue +65.0%
heavily indebted
Fell on sound metrics, Profitable but deeply down, Monthly spike, Halved from offer2026-01-29$962M$4.85-27.4%-61.3%8.9Strong Buy (9)$16.76 +246%
YSSYork Space Systems, Inc.Mixed +1
medium
loss-making -50.1%
revenue +52.3%
heavily indebted
Downgrade, Upgrade, Weakening confidence, Large daily move, Halved from offer2026-01-29$784M$3.58-45.8%-83.7%3.1Buy (13)$11.17 +93%
VTIXVirtuix Holdings Inc.Down -4
weak
pre-revenue
revenue +18.4%
liquidity 0.7
Thin liquidity, Halved from offer2026-01-27$20M$0.41-65.0%—7.5Buy (2)$8.50 +1962%
EQPTEquipmentShare.com Inc.Mixed +1
medium
profitable 1.4%
revenue +16.3%
heavily indebted
—2026-01-23$3.9B$14.11-28.0%-31.2%5.9Buy (11)$28.70 +103%
BTGOBitgo Holdings, Inc.Mixed -1
medium
loss-making -0.5%
revenue -50.9%
heavily indebted
Fell, analysts held, Shrinking revenue, Halved from offer2026-01-22$496M$3.57-25.8%-75.8%8.3Strong Buy (12)$9.54 +167%
AKTSAktis Oncology, Inc.Up +4
strong
pre-revenue
revenue +336.9%
heavily indebted
—2026-01-09$927M$16.40-32.8%-14.8%9.5Strong Buy (10)$35.88 +119%
ANDGAndersen Group Inc.Leans down -2
medium
profitable 3.7%
revenue +23.7%
Large daily move2025-12-17$6.8B$57.62+22.6%+280.1%6.3Buy (8)$68.71 +19%
MDLNMedline Inc.Mixed 0
weak
profitable 1.8%
revenue +18.2%
heavily indebted
—2025-12-17$51.9B$37.84+13.2%+15.5%7.0Buy (27)$45.35 +20%
WLTHWealthfront CorporationLeans up +2
weak
loss-making -19.4%
revenue +18.2%
—2025-12-12$1.7B$10.46+17.0%-24.8%3.8Buy (8)$12.46 +19%
LMRILumexa Imaging Holdings, Inc.Mixed +1
medium
loss-making -2.7%
revenue +7.8%
heavily indebted
—2025-12-11$1.4B$14.06+25.4%-33.5%9.0Strong Buy (10)$18.11 +29%
CDNLCardinal Infrastructure Group Inc.Mixed -1
medium
profitable 2.7%
revenue +113.9%
heavily indebted
Profitable but deeply down, Downgrade, Weakening confidence, Large daily move, Weekly spike, Monthly spike, Halved from offer2025-12-10$307M$5.18-83.5%-67.5%6.0Buy (5)$10.50 +103%
REEDReed's, Inc.Leans down -3
weak
loss-making -63.5%
revenue -10.2%
liquidity 0.8
Shrinking revenue, Thin liquidity, Value trap, Large daily move, Weekly spike, Monthly spike2025-12-05$68M$1.47+117.8%————
CBCCentral Bancompany, Inc.Down -6
weak
profitable 39.6%
revenue +13.8%
Downgrade, Weakening confidence, Below target2025-11-20$9.1B$37.20+17.2%—1.0Hold (5)$36.30 -2%
AEROGrupo Aeroméxico, S.A.B. de C.V.Mixed 0
medium
profitable 2.7%
revenue -4.6%
liquidity 0.6
Thin liquidity2025-11-06$2.4B$15.83+5.3%-19.5%6.7Buy (9)$26.16 +65%
BLLNBillionToOne, Inc.Up +4
strong
profitable 11.3%
revenue +47.2%
heavily indebted
Improving confidence2025-11-06$5.0B$90.20+12.0%+69.8%7.5Buy (8)$128.29 +42%
XZOExzeo Group, Inc.Mixed +1
medium
profitable 39.7%
revenue +0.0%
heavily indebted
—2025-11-05$1.4B$15.18+3.3%-14.6%8.3Strong Buy (3)$25.25 +66%
BETABETA Technologies, Inc.Leans down -2
medium
pre-revenue
revenue +98.2%
heavily indebted
Downgrade, Weakening confidence, Large daily move2025-11-04$5.5B$18.83-8.9%-48.4%7.2Buy (9)$31.33 +66%
NAVNNavan, Inc.Mixed +1
medium
loss-making -42.1%
revenue +35.4%
heavily indebted
—2025-10-30$6.6B$24.33-11.5%+1.3%8.7Strong Buy (15)$30.80 +27%
MPLTMapLight Therapeutics, Inc.Leans up +3
medium
—Halved from offer2025-10-27$403M$6.42-35.5%-58.3%7.7Strong Buy (15)$26.54 +313%
QQnity Electronics, Inc.Leans up +2
medium
profitable 10.2%
revenue +9.7%
heavily indebted
—2025-10-27$24.7B$113.63-15.9%—8.5Strong Buy (10)$173.30 +53%
OWLSObook Holdings Inc.Leans down -2
weak
revenue +3.9%
liquidity 0.6
Thin liquidity, Monthly spike, Halved from offer2025-10-16$193M$2.04-59.9%————
SEVAptera Motors Corp.Mixed -1
weak
heavily indebted
Weekly spike, Halved from offer2025-10-16$70M$1.68-27.6%—10.0Strong Buy (2)$6.33 +277%
ALHAlliance Laundry Holdings Inc.Mixed +1
medium
profitable 11.7%
revenue +5.3%
heavily indebted
—2025-10-09$4.6B$23.92-4.7%+7.0%8.1Strong Buy (8)$31.00 +30%
PXEDPhoenix Education Partners, Inc.Leans down -2
medium
profitable 8.7%
revenue +1.0%
heavily indebted
Downgrade, Weakening confidence2025-10-09$701M$20.52-28.9%-27.1%3.8Buy (8)$28.43 +39%
TTRXTurn Therapeutics Inc.Mixed -1
weak
heavily indebted
Large daily move2025-10-08$278M$8.64-5.7%—10.0Strong Buy (2)$25.00 +189%
FRMIFermi Inc.Leans down -3
medium
liquidity 0.6
heavily indebted
Thin liquidity, Weakening confidence, Large daily move, Weekly spike, Halved from offer2025-10-01$1.7B$2.06-57.5%-82.5%7.5Buy (8)$15.63 +659%
NPNeptune Insurance Holdings Inc.Mixed +1
medium
profitable 22.7%
revenue +33.7%
liquidity 0.9
Thin liquidity2025-10-01$3.9B$28.39-10.0%+49.1%5.0Buy (13)$34.12 +20%
PTRNPattern Group Inc.Leans up +3
medium
profitable 3.6%
revenue +39.3%
heavily indebted
Upgrade2025-09-19$3.6B$18.86-1.4%+32.4%8.9Strong Buy (9)$27.88 +48%
NTSKNetskope, Inc.Down -4
strong
loss-making -91.8%
revenue +31.7%
heavily indebted
Downgrade, Below target2025-09-18$8.9B$24.80+42.6%+18.2%7.4Buy (19)$20.97 -15%
STUBStubHub Holdings, Inc.Up +4
strong
loss-making -91.3%
revenue -1.4%
heavily indebted
Fell, analysts held, Improving confidence, Halved from offer2025-09-17$2.0B$4.84-25.4%-77.8%5.4Buy (14)$9.21 +90%
WBIWaterBridge Infrastructure LLCLeans up +3
medium
profitable 1.2%
revenue +66.2%
heavily indebted
Improving confidence2025-09-17$3.4B$24.99-13.6%+55.5%5.6Buy (8)$36.75 +47%
BRCBBlack Rock Coffee Bar, Inc.Mixed -1
medium
profitable 1.6%
revenue +24.5%
liquidity 0.6
heavily indebted
Profitable but deeply down, Thin liquidity, Weakening confidence, Large daily move, Halved from offer2025-09-12$541M$10.59+36.6%-46.6%4.4Buy (8)$12.43 +17%
GEMIGemini Space Station, Inc.Mixed -1
medium
loss-making -250.1%
revenue +26.3%
heavily indebted
Large daily move, Halved from offer2025-09-12$311M$1.71-34.2%-90.8%0.5Hold (10)$5.08 +198%
LGNLegence Corp.Mixed 0
medium
loss-making -1.2%
revenue +21.5%
heavily indebted
Weekly spike2025-09-12$3.8B$35.09-50.0%+63.1%8.8Strong Buy (17)$72.18 +106%
VIAVia Transportation, Inc.Leans up +2
medium
loss-making -15.3%
revenue +28.6%
heavily indebted
—2025-09-12$3.5B$45.72+69.3%-9.5%8.0Strong Buy (10)$52.33 +14%
FIGRFigure Technology Solutions, Inc.Up +6
strong
profitable 33.7%
revenue +55.7%
heavily indebted
Improving confidence2025-09-11$5.7B$25.84-29.5%-3.3%6.5Buy (10)$47.20 +83%
LBRXLB Pharmaceuticals IncMixed 0
weak
——2025-09-11$1.4B$40.04-7.0%+166.5%8.2Strong Buy (11)$58.00 +45%
KLARKlarna Group plcMixed -1
medium
loss-making -3.5%
revenue +24.9%
heavily indebted
Weakening confidence, Large daily move, Halved from offer2025-09-10$5.2B$12.67-29.3%-66.1%4.2Buy (25)$19.24 +52%
VNOMViper Energy, Inc.Mixed +1
medium
profitable 12.1%
revenue +62.1%
heavily indebted
—2025-08-19$15.3B$39.74-1.6%—8.3Strong Buy (20)$55.45 +40%
BUUUBUUU Group LimitedMixed -1
weak
revenue +14.4%
heavily indebted
Large daily move2025-08-14$1.1B$3.78+93.1%+45.4%———
MIAXMiami International Holdings, Inc.Mixed +1
medium
profitable 19.8%
revenue +19.6%
—2025-08-14$3.7B$36.66-12.6%+63.1%3.6Buy (7)$44.80 +22%
BLSHBullishMixed 0
medium
loss-making -0.7%
revenue -2.1%
heavily indebted
Fell, analysts held, Halved from offer2025-08-13$3.4B$19.96-9.9%-35.7%4.3Buy (14)$39.92 +100%
HTFLHeartFlow, Inc.Leans up +3
medium
loss-making -55.8%
revenue +39.9%
heavily indebted
Improving confidence, Large daily move2025-08-08$4.3B$44.63+15.6%+165.2%7.8Strong Buy (9)$63.13 +41%
FLYFirefly Aerospace Inc.Leans up +3
medium
loss-making -88.4%
revenue +162.9%
heavily indebted
Fell on sound metrics, Weekly spike, Monthly spike, Halved from offer2025-08-07$4.3B$19.52-7.2%-56.0%5.9Buy (11)$36.64 +88%
WYFIWhiteFiber, Inc.Leans up +2
medium
loss-making -132.2%
revenue +66.2%
heavily indebted
Fell on sound metrics, Large daily move, Halved from offer2025-08-07$427M$7.65-68.9%-42.2%8.2Strong Buy (11)$31.45 +311%
FIGFigma, Inc.Up +4
strong
loss-making -40.2%
revenue +41.0%
heavily indebted
Fell on sound metrics2025-07-31$10.4B$16.26-22.2%-30.4%2.8Buy (16)$27.41 +69%
SIShoulder Innovations, Inc.Mixed 0
weak
loss-making -51.7%
revenue +49.6%
heavily indebted
—2025-07-31$433M$20.31+3.9%+29.7%8.8Strong Buy (4)$27.00 +33%
AMBQAmbiq Micro, Inc.Up +4
weak
loss-making -29.7%
revenue -4.7%
Improving confidence, Weekly spike2025-07-30$1.2B$45.60-30.1%+122.1%6.4Buy (7)$66.71 +46%
ARXAccelerant HoldingsLeans down -3
medium
profitable 5.3%
revenue +47.1%
heavily indebted
Under acquisition, Weakening confidence2025-07-24$4.3B$19.86+1.6%-5.9%-0.8Hold (6)$20.25 +2%
MHMcGraw Hill, Inc.Mixed -1
weak
profitable 3.5%
revenue +0.1%
liquidity 0.9
heavily indebted
Thin liquidity2025-07-24$2.2B$11.82-9.2%-19.7%8.1Strong Buy (13)$17.33 +47%
CARLCarlsmed, Inc.Mixed 0
medium
loss-making -55.8%
revenue +85.9%
heavily indebted
—2025-07-23$469M$17.22+24.2%+18.1%8.0Strong Buy (5)$22.00 +28%
NIQNIQ Global Intelligence plcMixed 0
weak
loss-making -2.6%
revenue +5.7%
heavily indebted
—2025-07-23$5.7B$16.79+12.2%-10.3%6.8Buy (14)$23.04 +37%
MGRTMega Fortune Company LimitedMixed 0
weak
revenue +233.3%
heavily indebted
—2025-07-16$1.6B$135.00+18.0%+0.3%———
JCAPJefferson Capital, Inc.Leans up +2
medium
profitable 23.5%
revenue +41.5%
heavily indebted
Large daily move2025-06-26$1.2B$20.94-11.7%+42.4%7.0Buy (5)$28.60 +37%
CAICaris Life Sciences, Inc.Mixed +1
medium
profitable 9.2%
revenue +97.0%
heavily indebted
—2025-06-18$6.6B$18.54+6.5%+39.6%6.8Buy (14)$34.23 +85%
SLDESlide Insurance Holdings, Inc.Mixed +1
medium
profitable 39.3%
revenue +36.5%
heavily indebted
—2025-06-18$3.0B$26.85+19.3%+60.9%4.0Buy (5)$30.00 +12%
CHYMChime Financial, Inc.Mixed +1
medium
profitable 3.0%
revenue +30.7%
heavily indebted
—2025-06-12$12.9B$30.85+6.7%+13.2%7.8Strong Buy (23)$41.90 +36%
ASICAtegrity Specialty Insurance Company HoldingsLeans up +2
weak
profitable 18.8%
revenue +23.4%
—2025-06-11$1.2B$25.03+1.3%+44.7%6.0Buy (5)$28.40 +13%
VOYGVoyager Technologies, Inc.Mixed 0
medium
loss-making -79.0%
revenue +15.4%
heavily indebted
Halved from offer2025-06-11$1.7B$22.02-38.5%-10.6%5.9Buy (11)$40.36 +83%
OMDAOmada Health, Inc.Mixed +1
medium
profitable 4.2%
revenue +53.2%
—2025-06-06$889M$12.50-39.7%-10.8%6.3Buy (12)$26.50 +112%
CRCLCircle Internet Group, Inc.Leans up +3
medium
profitable 15.3%
revenue +63.9%
—2025-06-05$16.0B$51.88-16.6%+113.1%4.1Buy (29)$102.37 +97%
HNGEHinge Health, Inc.Mixed 0
medium
profitable 21.0%
revenue +50.6%
heavily indebted
—2025-05-22$9.4B$108.10+31.3%+259.7%7.4Buy (17)$135.38 +25%
MNTNMNTN, Inc.Leans down -2
medium
profitable 17.8%
revenue +28.6%
heavily indebted
Profitable but deeply down, Downgrade, Weakening confidence, Monthly spike, Halved from offer2025-05-22$382M$4.67-59.5%-44.4%5.0Buy (11)$9.67 +107%
VMETVersamet Royalties CorporationMixed -1
weak
profitable 43.4%
revenue +189.1%
liquidity 0.4
heavily indebted
Thin liquidity2025-05-20$866M$6.85-22.2%————
ARAIArrive AI Inc.Down -4
weak
pre-revenue
revenue -83.8%
liquidity 0.9
heavily indebted
Shrinking revenue, Thin liquidity, Value trap, Large daily move, Weekly spike, Monthly spike2025-05-15$2M$1.55-81.1%————
ETOReToro Group Ltd.Up +4
strong
profitable 2.4%
revenue +9.4%
heavily indebted
Fell on sound metrics, Profitable but deeply down, Halved from offer2025-05-14$1.8B$19.50-20.0%-57.5%6.0Buy (15)$36.60 +88%
AIIAmerican Integrity Insurance Group, Inc.Leans up +2
medium
profitable 26.2%
revenue +35.3%
heavily indebted
—2025-05-08$547M$29.12+11.6%+91.0%5.0Buy (6)$30.75 +6%
CHAChagee Holdings LimitedLeans up +3
medium
profitable 10.2%
revenue +4.0%
heavily indebted
Profitable but deeply down, Halved from offer2025-04-17$2.7B$13.63+41.6%-47.7%7.3Buy (11)$15.59 +14%
SMASmartStop Self Storage REIT, Inc.Down -7
strong
profitable 10.3%
revenue +18.6%
liquidity 0.5
heavily indebted
Thin liquidity, Downgrade, Weakening confidence, Below target2025-04-02$2.5B$39.11+16.9%+27.2%3.6Buy (11)$37.73 -4%
NMAXNewsmax Inc.Mixed 0
weak
loss-making -3.1%
revenue +10.7%
heavily indebted
Large daily move, Weekly spike2025-03-31$1.2B$7.32-7.5%+4.3%8.3Strong Buy (3)$15.67 +114%
CRWVCoreWeave, Inc.Mixed -1
medium
loss-making -25.6%
revenue +167.9%
liquidity 0.4
heavily indebted
Thin liquidity2025-03-28$29.5B$44.91-49.9%+43.6%6.1Buy (41)$115.34 +157%
NTHINeOnc Technologies Holdings, Inc.Mixed -1
weak
revenue -51.8%
liquidity 0.4
Shrinking revenue, Thin liquidity, Value trap, Improving confidence, Weekly spike, Monthly spike, Halved from offer2025-03-26$136M$3.48+0.0%—8.8Strong Buy (4)$17.00 +389%
KMTSKestra Medical Technologies, Ltd.Mixed +1
medium
loss-making -140.4%
revenue +59.0%
heavily indebted
—2025-03-06$1.7B$26.63+3.0%+74.4%7.8Strong Buy (9)$31.13 +17%
HMRHeidmar Maritime Holdings Corp.Leans down -3
weak
loss-making -23.6%
revenue +92.9%
liquidity 0.8
Thin liquidity, Halved from offer2025-02-20$68M$1.01-14.7%—7.5Buy (2)$3.00 +197%
NPBNorthpointe Bancshares, Inc.Mixed +1
weak
profitable 34.9%
revenue +29.2%
heavily indebted
—2025-02-14$534M$14.65-10.9%+7.3%3.3Buy (3)$18.08 +23%
AARDAardvark Therapeutics, Inc.Down -8
medium
—Downgrade, Weakening confidence, Junk zone, Large daily move, Monthly spike, Halved from offer2025-02-13$29M$1.00-80.3%-91.5%2.3Hold (11)$4.57 +357%
KRMNKarman Holdings Inc.Up +4
strong
profitable 7.5%
revenue +36.6%
heavily indebted
Improving confidence2025-02-13$5.4B$32.99-34.2%+58.6%8.6Strong Buy (14)$67.00 +103%
SAILSailPoint, Inc.Mixed 0
weak
loss-making -16.9%
revenue +24.4%
—2025-02-13$11.9B$22.04+11.8%-9.7%5.9Buy (27)$22.00 -0%
TTAMTitan America SALeans down -3
medium
profitable 9.2%
revenue +1.8%
heavily indebted
—2025-02-07$2.1B$10.87-27.9%-12.1%2.1Hold (7)$15.00 +38%
INRInfinity Natural Resources, Inc.Mixed -1
medium
profitable 7.9%
revenue +37.6%
liquidity 0.7
heavily indebted
Thin liquidity2025-01-31$821M$11.74-6.6%-29.3%8.9Strong Buy (9)$21.11 +80%
MAZEMaze Therapeutics, Inc.Mixed -1
weak
pre-revenue
revenue -100.0%
heavily indebted
Shrinking revenue2025-01-31$1.9B$32.43+22.8%+90.6%9.6Strong Buy (14)$62.46 +93%
BBNXBeta Bionics, Inc.Leans up +3
medium
loss-making -65.3%
revenue +53.9%
—2025-01-30$893M$13.32-6.5%-2.2%6.7Buy (15)$25.10 +88%
SFDSmithfield Foods, Inc.Leans down -2
medium
profitable 5.9%
revenue +9.8%
heavily indebted
Weakening confidence2025-01-28$7.6B$18.82-15.1%-8.0%5.0Buy (7)$22.79 +21%
AAPGAscentage Pharma Group InternationalMixed 0
medium
revenue -41.5%
heavily indebted
Fell, analysts held, Shrinking revenue2025-01-24$1.3B$12.44-19.7%-25.5%8.6Strong Buy (11)$44.50 +258%
VGVenture Global, Inc.Leans up +3
medium
profitable 31.1%
revenue +176.9%
liquidity 0.9
heavily indebted
Profitable but deeply down, Thin liquidity, Improving confidence2025-01-24$33.1B$12.13-4.4%-41.3%5.0Buy (17)$17.56 +45%
FLOCFlowco Holdings Inc.Mixed 0
medium
profitable 6.4%
revenue +41.9%
heavily indebted
—2025-01-16$1.9B$20.78-9.1%-15.1%7.2Buy (9)$29.78 +43%
AVRAnteris Technologies Global Corp.Mixed -1
medium
pre-revenue
revenue -29.2%
heavily indebted
Shrinking revenue, Large daily move2024-12-13$528M$5.09-42.5%-8.2%8.0Strong Buy (5)$13.75 +170%
TTANServiceTitan, Inc.Mixed 0
weak
loss-making -12.1%
revenue +24.5%
heavily indebted
—2024-12-12$8.0B$76.94-6.5%+18.0%7.5Buy (18)$96.81 +26%
TTGTTechTarget, Inc.Leans down -3
weak
loss-making -24.9%
revenue +70.9%
heavily indebted
—2024-12-03$205M$2.59-24.9%—7.5Buy (2)$7.50 +190%
PONYPony AI Inc.Leans up +3
medium
loss-making -118.5%
revenue +20.0%
heavily indebted
Fell on sound metrics, Halved from offer2024-11-27$1.9B$3.52-44.1%-66.6%8.3Strong Buy (18)$18.69 +431%
SEPNSepterna, Inc.Mixed +1
medium
loss-making -61.3%
revenue +4174.5%
heavily indebted
—2024-10-25$2.0B$39.20-3.6%+109.3%9.5Strong Buy (10)$59.22 +51%
WRDWeRide Inc.Leans up +2
medium
loss-making -199.0%
revenue +89.6%
heavily indebted
Halved from offer2024-10-25$1.4B$3.27-31.9%-74.4%7.7Strong Buy (13)$12.30 +277%
INGMIngram Micro Holding CorporationMixed 0
weak
profitable 0.8%
revenue +9.5%
heavily indebted
—2024-10-24$6.5B$27.47+1.5%+37.0%4.0Buy (15)$32.85 +20%
CBLLCeriBell, Inc.Mixed +1
medium
loss-making -68.0%
revenue +36.1%
heavily indebted
—2024-10-11$1.0B$25.75+7.1%+55.9%9.4Strong Buy (8)$31.57 +23%
CBNAChain Bridge Bancorp, Inc.Leans up +2
medium
profitable 43.9%
revenue +3.8%
—2024-10-04$346M$51.75+12.1%+143.9%1.7Hold (3)$54.00 +4%
FVRFrontView REIT, Inc.Mixed 0
medium
loss-making -0.0%
revenue +341.0%
liquidity 0.9
heavily indebted
Thin liquidity2024-10-02$583M$18.06-4.1%-2.7%6.8Buy (11)$21.64 +20%
SAROStandardAero, Inc.Mixed -1
medium
profitable 5.5%
revenue +15.8%
heavily indebted
—2024-10-02$8.9B$26.96+1.2%+5.1%6.4Buy (14)$34.17 +27%
BKVBKV CorporationLeans up +3
medium
profitable 16.2%
revenue +41.6%
heavily indebted
—2024-09-26$2.1B$17.88-26.9%+22.4%9.6Strong Buy (11)$31.27 +75%
GRDNGuardian Pharmacy Services, Inc.Leans down -2
medium
profitable 5.1%
revenue +17.9%
heavily indebted
—2024-09-26$3.1B$46.67+30.3%+233.8%9.3Strong Buy (7)$50.14 +7%
BCAXBicara Therapeutics Inc.Leans up +2
weak
—Fell, analysts held, Monthly spike, Halved from offer2024-09-13$665M$9.12-59.8%-49.0%7.5Buy (14)$32.17 +253%
MBXMBX Biosciences, Inc.Up +4
weak
—Improving confidence2024-09-13$2.8B$53.41-18.0%+270.4%8.8Strong Buy (12)$95.09 +78%
ZBIOZenas BioPharma, Inc.Leans up +3
medium
pre-revenue
revenue +100.0%
—2024-09-13$1.9B$25.04-8.2%+61.0%8.8Strong Buy (8)$47.88 +91%
SEGSeaport Entertainment Group Inc.Mixed -1
weak
loss-making -91.4%
revenue +18.3%
heavily indebted
—2024-07-29$263M$20.50-24.9%————
CONConcentra Group Holdings Parent, Inc.Mixed +1
weak
profitable 9.3%
revenue +13.8%
heavily indebted
—2024-07-25$5.4B$41.45+19.8%+73.0%9.1Strong Buy (11)$45.90 +11%
LINELineage, Inc.Mixed -1
medium
loss-making -4.2%
revenue +0.3%
heavily indebted
Halved from offer2024-07-25$9.0B$32.40-13.5%-57.2%2.1Hold (21)$41.85 +29%
ARTVArtiva Biotherapeutics, Inc.Down -6
strong
revenue -100.0%
heavily indebted
Shrinking revenue, Downgrade, Weakening confidence, Halved from offer2024-07-19$198M$3.83-65.8%-66.3%3.3Buy (6)$20.75 +442%
ARDTArdent Health, Inc.Leans down -2
medium
profitable 2.3%
revenue +6.0%
heavily indebted
Below target, Monthly spike2024-07-18$2.5B$14.50+63.5%-24.6%4.6Buy (13)$16.63 +15%
TWFGTWFG, Inc.Mixed +1
weak
profitable 2.8%
revenue +20.8%
heavily indebted
—2024-07-18$1.4B$25.44-1.1%+54.4%5.6Buy (8)$31.71 +25%
SUNSSunrise Realty Trust, Inc.Mixed +1
weak
profitable 34.9%
revenue +143.2%
heavily indebted
—2024-07-09$98M$6.80-7.0%—7.5Buy (4)$10.13 +49%
ALMSAlumis Inc.Mixed -1
medium
pre-revenue
revenue -37.7%
heavily indebted
Shrinking revenue, Large daily move, Halved from offer2024-06-28$727M$4.33-78.0%-63.0%8.5Strong Buy (10)$27.38 +532%
LBLandBridge CorporationLeans up +2
medium
profitable 17.1%
revenue +81.1%
heavily indebted
—2024-06-28$5.6B$71.43-8.0%+424.8%4.3Buy (7)$89.57 +25%
TBNTamboran Resources CorporationMixed +1
weak
heavily indebted
—2024-06-27$948M$24.13-21.7%+23.9%8.6Strong Buy (7)$58.57 +143%
WBTNWEBTOON Entertainment Inc.Down -4
medium
loss-making -25.2%
revenue +2.5%
heavily indebted
Weakening confidence, Halved from offer2024-06-27$1.3B$9.12+16.8%-57.8%2.5Hold (8)$11.04 +21%
TEMTempus AI, Inc.Mixed +1
medium
loss-making -12.5%
revenue +83.4%
heavily indebted
—2024-06-14$13.1B$59.61+38.6%+99.7%4.5Buy (20)$89.56 +50%
RAPPRapport Therapeutics, Inc.Leans up +2
weak
pre-revenue
heavily indebted
—2024-06-07$1.6B$23.59-46.0%+58.2%9.7Strong Buy (16)$64.21 +172%
WAYWaystar Holding Corp.Mixed +1
medium
profitable 10.7%
revenue +16.5%
heavily indebted
—2024-06-07$5.4B$27.09+13.4%+29.2%8.3Strong Buy (23)$34.82 +29%
INBXInhibrx Biosciences, Inc.Leans up +3
weak
revenue +550.0%
Improving confidence2024-05-28$1.2B$74.33-9.5%—7.5Buy (4)$266.67 +259%
BOWBowhead Specialty Holdings Inc.Down -4
strong
profitable 9.3%
revenue +29.6%
heavily indebted
Weakening confidence2024-05-23$1.1B$34.27+2.0%+100.1%0.7Hold (7)$34.33 +0%
HDLSuper Hi International Holding Ltd.Mixed -1
medium
profitable 1.2%
revenue +8.0%
heavily indebted
Profitable but deeply down, Halved from offer2024-05-17$678M$10.70-24.2%-46.7%3.3Buy (3)$17.60 +64%
NNENANO Nuclear Energy Inc.Leans up +3
weak
pre-revenue
—2024-05-08$597M$9.97-43.3%+174.0%7.2Buy (9)$34.75 +249%
VIKViking Holdings LtdLeans up +3
medium
profitable 19.3%
revenue +21.9%
liquidity 0.8
heavily indebted
Thin liquidity, Upgrade, Improving confidence2024-05-01$40.1B$95.00-10.0%+272.6%8.9Strong Buy (23)$110.05 +16%
LOARLoar Holdings Inc.Mixed -1
medium
profitable 9.4%
revenue +23.2%
heavily indebted
—2024-04-25$7.0B$66.25-3.9%+140.8%7.0Buy (5)$88.80 +34%
MRXMarex Group LimitedMixed -1
medium
profitable 8.9%
revenue +25.4%
heavily indebted
—2024-04-25$5.1B$61.42-1.0%+265.0%7.2Buy (9)$82.88 +35%
RBRKRubrik, Inc.Mixed 0
medium
loss-making -16.5%
revenue +48.5%
—2024-04-25$22.8B$114.56+8.8%+272.3%9.3Strong Buy (29)$122.93 +7%
CTRICenturi Holdings, Inc.Mixed 0
weak
profitable 1.4%
revenue +13.1%
heavily indebted
—2024-04-18$2.2B$21.03-8.7%+8.6%3.8Buy (8)$27.86 +32%
IBTAIbotta, Inc.Mixed 0
medium
loss-making -4.5%
revenue -6.8%
heavily indebted
Upgrade, Improving confidence, Below target2024-04-18$1.3B$53.98+60.2%-43.6%0.0Hold (9)$50.57 -6%
ULSUL Solutions Inc.Leans up +3
medium
profitable 16.1%
revenue +6.4%
heavily indebted
Improving confidence2024-04-12$16.2B$74.88+4.2%+174.2%5.8Buy (13)$96.45 +29%
PACSPACS Group, Inc.Mixed -1
weak
profitable 4.9%
revenue +29.3%
liquidity 0.8
heavily indebted
Thin liquidity2024-04-11$7.7B$43.03+9.0%+111.5%8.3Strong Buy (6)$62.50 +45%
CTNMContineum Therapeutics, Inc.Mixed +1
weak
heavily indebted
—2024-04-05$387M$9.04-32.1%-38.1%6.9Buy (8)$21.43 +137%
AUNAAuna S.A.Up +4
strong
profitable 0.3%
revenue -0.0%
heavily indebted
Fell on sound metrics, Profitable but deeply down, Halved from offer2024-03-22$340M$3.90-14.7%-63.2%6.4Buy (7)$6.99 +79%
RDDTReddit, Inc.Mixed +1
medium
profitable 32.1%
revenue +69.4%
Downgrade2024-03-21$19.0B$89.88-40.1%+177.0%3.9Buy (32)$148.46 +65%
ALABAstera Labs, Inc.Up +4
medium
profitable 29.6%
revenue +115.1%
—2024-03-20$38.8B$211.60-30.7%+642.1%6.0Buy (25)$344.15 +63%
SERVServe Robotics Inc.Leans down -3
medium
pre-revenue
revenue +46.2%
heavily indebted
Downgrade, Weakening confidence, Large daily move, Halved from offer2024-03-06$230M$2.29-46.5%—7.1Buy (7)$8.18 +257%
UMACUnusual Machines, Inc.Leans up +2
medium
loss-making -75.9%
revenue +101.2%
—2024-02-14$586M$10.15-62.6%+238.2%8.3Strong Buy (9)$30.11 +197%
TBBBBBB Foods Inc.Down -5
strong
loss-making -2.0%
revenue +36.1%
liquidity 0.7
heavily indebted
Thin liquidity, Downgrade, Improving confidence, Below target2024-02-09$8.9B$66.84+44.5%+247.4%6.2Buy (13)$66.45 -1%
KYTXKyverna Therapeutics, Inc.Leans up +2
weak
heavily indebted
Fell, analysts held, Halved from offer2024-02-08$319M$4.37-43.6%-75.5%8.3Strong Buy (6)$30.40 +596%
AHRAmerican Healthcare REIT, Inc.Leans down -3
medium
profitable 3.6%
revenue +9.2%
liquidity 0.6
heavily indebted
Thin liquidity2024-02-07$13.5B$57.61+5.7%+347.2%8.1Strong Buy (16)$66.31 +15%
ANROAlto Neuroscience, Inc.Mixed 0
weak
heavily indebted
—2024-02-02$1.2B$26.51-12.1%+62.8%9.1Strong Buy (11)$38.67 +46%
ASAmer Sports, Inc.Leans up +2
medium
profitable 7.3%
revenue +26.7%
heavily indebted
—2024-02-01$17.4B$29.51-8.1%+124.5%8.5Strong Buy (27)$47.47 +61%
AVBPArriVent BioPharma, Inc.Mixed +1
weak
—Fell, analysts held2024-01-26$673M$11.26-55.1%-29.3%10.0Strong Buy (11)$26.40 +134%
BTSGBrightSpring Health Services, Inc.Mixed -1
medium
profitable 2.7%
revenue +28.2%
heavily indebted
—2024-01-26$14.8B$64.02+17.9%+440.5%9.2Strong Buy (18)$83.21 +30%
CGONCG Oncology, Inc.Mixed +1
medium
pre-revenue
revenue +254.7%
—2024-01-25$6.6B$81.90-3.5%+219.3%7.9Strong Buy (14)$92.15 +13%
KSPIJoint Stock Company Kaspi.kzLeans up +2
medium
profitable 24.3%
revenue +59.8%
heavily indebted
—2024-01-19$17.1B$85.80-9.2%-0.5%5.7Buy (7)$106.52 +24%
PSBDPalmer Square Capital BDC Inc.Leans down -3
medium
profitable 127.1%
revenue -97.8%
heavily indebted
Shrinking revenue2024-01-18$320M$9.63-3.9%-39.3%0.0Hold (6)$10.46 +9%
SDHCSmith Douglas Homes Corp.Mixed 0
medium
profitable 0.5%
revenue -0.5%
heavily indebted
Profitable but deeply down, Halved from offer2024-01-11$470M$8.20-33.9%-53.2%-0.8Hold (6)$9.67 +18%
NBBKNB Bancorp, Inc.Mixed 0
weak
profitable 23.6%
revenue +23.0%
heavily indebted
—2023-12-28$894M$21.14-4.5%—2.5Hold (2)$25.00 +18%
HGHamilton Insurance Group, Ltd.Mixed 0
medium
profitable 16.5%
revenue +24.4%
heavily indebted
—2023-11-10$3.8B$37.79+8.9%+151.4%3.6Buy (7)$39.86 +5%
MNRMach Natural Resources LPLeans up +3
medium
profitable 20.7%
revenue +21.2%
liquidity 0.8
Fell on sound metrics, Profitable but deeply down, Thin liquidity, Halved from offer2023-10-25$1.5B$8.09-28.8%-45.3%7.8Strong Buy (9)$16.29 +101%
AIREreAlpha Tech Corp.Mixed 0
weak
pre-revenue
revenue +376.4%
heavily indebted
Monthly spike2023-10-23$3M$0.37-75.7%————
BIRKBirkenstock Holding plcMixed -1
medium
profitable 14.8%
revenue +16.2%
heavily indebted
Weakening confidence2023-10-11$6.5B$34.38-4.1%-24.9%6.3Buy (24)$50.36 +46%
MDCXMedicus Pharma Ltd.Down -8
medium
liquidity 0.7
Thin liquidity, Downgrade, Large daily move, Monthly spike2023-10-11$4M$1.16-85.0%—5.0Buy (3)$32.50 +1567%
NATLNCR Atleos CorporationDown -5
medium
profitable 6.1%
revenue +1.1%
liquidity 0.9
heavily indebted
Thin liquidity, Under acquisition2023-10-11$3.6B$47.68+4.2%—0.0Hold (3)$50.20 +5%
ANLAdlai Nortye Group Ltd.Leans up +2
weak
heavily indebted
Fell, analysts held2023-09-29$683M$9.06-20.5%-58.0%10.0Strong Buy (7)$29.50 +226%
KVYOKlaviyo, Inc.Mixed 0
medium
profitable 0.5%
revenue +31.6%
heavily indebted
—2023-09-20$6.2B$21.30+26.2%-22.4%7.8Strong Buy (23)$26.98 +27%
SRBKSR Bancorp, Inc.Mixed 0
weak
profitable 10.0%
revenue +0.4%
heavily indebted
—2023-09-20$139M$18.39-5.2%————
CARTMaplebear Inc.Down -4
weak
profitable 11.6%
revenue +10.8%
Under acquisition, Downgrade, Weakening confidence2023-09-19$13.9B$57.84+20.5%+94.4%2.1Hold (29)$61.57 +6%
ARMArm Holdings plcLeans up +2
medium
profitable 17.1%
revenue +22.8%
heavily indebted
—2023-09-14$203.9B$177.17-29.8%+321.0%5.4Buy (43)$272.43 +54%
PODCPodcastOne, Inc.Mixed 0
weak
loss-making -5.0%
revenue +18.3%
—2023-09-08$69M$1.83-19.3%—10.0Strong Buy (3)$5.67 +210%
VFSVinFast Auto Ltd.Leans down -2
medium
loss-making -82.1%
revenue +104.9%
liquidity 0.5
Thin liquidity2023-08-15$7.1B$2.69-2.2%—6.7Buy (3)$5.57 +107%
SNSharkNinja, Inc.Mixed +1
medium
profitable 11.6%
revenue +15.8%
heavily indebted
—2023-07-31$31.9B$216.80+23.3%—9.3Strong Buy (14)$249.17 +15%
ODDOddity Tech Ltd.Down -4
strong
profitable 1.3%
revenue +25.2%
heavily indebted
Profitable but deeply down, Weakening confidence, Sell majority, Below target, Halved from offer2023-07-19$813M$13.61+45.8%-47.0%-1.8Hold (11)$16.94 +24%
SGMTSagimet Biosciences Inc.Leans up +2
weak
——2023-07-14$729M$9.62-2.0%-37.2%7.5Buy (12)$27.27 +183%
VTMXCorporación Inmobiliaria Vesta, S.A.B. de C.V.Mixed -1
medium
profitable 156.7%
revenue +12.2%
heavily indebted
—2023-06-30$3.5B$34.51+10.8%+16.6%2.5Hold (4)$38.48 +12%
KGSKodiak Gas Services, Inc.Leans up +2
medium
profitable 11.3%
revenue +12.8%
heavily indebted
—2023-06-29$4.5B$42.69-32.4%+198.0%8.3Strong Buy (15)$72.64 +70%
PLGOPelagos Insurance Capital LimitedLeans down -3
medium
profitable 14.2%
revenue +2.9%
heavily indebted
Below target2023-06-29$2.3B$27.31+22.3%—0.6Hold (9)$26.94 -1%
SVVSavers Value Village, Inc.Mixed -1
medium
profitable 3.5%
revenue +9.2%
liquidity 0.7
heavily indebted
Profitable but deeply down, Thin liquidity, Halved from offer2023-06-29$1.6B$9.42-0.9%-45.1%6.7Buy (12)$14.23 +51%
CAVACAVA Group, Inc.Leans up +2
weak
profitable 4.5%
revenue +22.4%
heavily indebted
Improving confidence2023-06-15$6.8B$51.23-18.0%+177.7%6.1Buy (27)$75.42 +47%
ATMUAtmus Filtration Technologies Inc.Mixed +1
medium
profitable 11.3%
revenue +5.7%
heavily indebted
—2023-05-26$4.5B$53.23+8.2%+167.3%7.0Buy (5)$62.20 +17%
ATSATS CorporationMixed +1
weak
profitable 0.3%
revenue +17.4%
heavily indebted
Profitable but deeply down2023-05-25$1.7B$17.18-10.7%-52.3%———
KVUEKenvue Inc.Leans down -3
medium
profitable 10.9%
revenue -2.1%
liquidity 1.0
heavily indebted
Thin liquidity, Under acquisition2023-05-04$37.3B$19.31—-11.7%1.5Hold (10)$19.50 +1%
AESIAtlas Energy Solutions Inc.Mixed +1
weak
loss-making -13.0%
revenue +3.7%
heavily indebted
Fell, analysts held, Monthly spike, Halved from offer2023-03-09$698M$5.62-56.5%-52.9%3.5Buy (13)$15.38 +174%
ENLTEnlight Renewable Energy LtdLeans down -2
medium
profitable 13.4%
revenue +46.0%
liquidity 0.8
heavily indebted
Thin liquidity2023-02-10$9.3B$62.01-20.9%+257.2%2.5Hold (8)$81.14 +31%
MLYSMineralys Therapeutics, Inc.Mixed -1
medium
heavily indebted
—2023-02-10$1.4B$14.16-41.1%-2.8%8.2Strong Buy (11)$43.56 +208%
HSAIHesai GroupMixed +1
medium
profitable 8.9%
revenue +45.8%
heavily indebted
—2023-02-09$2.3B$12.77-20.2%-34.9%8.2Strong Buy (19)$23.37 +83%
NXTNextpower Inc.Up +4
medium
profitable 16.0%
revenue +20.3%
Improving confidence2023-02-09$14.3B$75.95-4.1%+244.0%7.7Strong Buy (30)$127.90 +68%
ASSTStrive, Inc.Up +5
medium
pre-revenue
revenue +49.0%
Improving confidence2023-02-03$2.7B$16.61+61.8%+314.2%9.0Strong Buy (5)$40.60 +144%
GPCRStructure Therapeutics Inc.Leans up +3
weak
——2023-02-03$1.4B$17.12-62.8%+34.1%8.0Strong Buy (15)$104.86 +512%
TXOTXO Partners, L.P.Mixed -1
weak
loss-making -20.5%
revenue +41.8%
liquidity 0.6
Thin liquidity2023-01-27$741M$12.62-3.5%-30.8%10.0Strong Buy (4)$19.75 +56%
SKWDSkyward Specialty Insurance Group, Inc.Mixed -1
medium
profitable 10.6%
revenue +23.7%
heavily indebted
—2023-01-13$2.8B$63.54+9.5%+325.6%5.4Buy (13)$71.09 +12%
VTSVitesse Energy, Inc.Mixed -1
weak
loss-making -15.4%
revenue +13.2%
liquidity 0.7
heavily indebted
Thin liquidity, Improving confidence2023-01-10$650M$14.55-7.3%—7.5Buy (4)$21.50 +48%
ECXECARX Holdings Inc.Leans down -2
weak
loss-making -7.4%
revenue +9.9%
liquidity 0.6
Thin liquidity2022-12-21$318M$0.69-27.7%—10.0Strong Buy (4)$2.70 +291%
ATATAtour Lifestyle Holdings LimitedLeans up +2
medium
profitable 15.5%
revenue +35.1%
heavily indebted
—2022-11-11$5.2B$38.41+8.1%+226.5%9.1Strong Buy (21)$49.43 +29%
ASPIASP Isotopes Inc.Leans down -2
medium
pre-revenue
revenue +475.5%
heavily indebted
—2022-11-10$267M$1.14-56.7%-59.3%10.0Strong Buy (3)$13.00 +1045%
MBLYMobileye Global Inc.Leans down -2
weak
loss-making -201.2%
revenue +14.5%
Weakening confidence, Halved from offer2022-10-26$4.7B$5.09-39.8%-73.9%2.8Buy (23)$9.29 +83%
PRMEPrime Medicine, Inc.Up +4
strong
pre-revenue
revenue +55.3%
heavily indebted
Fell on sound metrics, Large daily move, Halved from offer2022-10-20$762M$3.84+34.7%-76.0%7.3Buy (13)$7.03 +83%
XPERXperi Inc.Mixed +1
weak
loss-making -6.9%
revenue -9.2%
heavily indebted
Halved from offer2022-09-20$296M$5.42-6.6%—8.0Strong Buy (5)$11.40 +110%
CRBGCorebridge Financial, Inc.Mixed +1
medium
profitable 10.9%
revenue -5.1%
heavily indebted
—2022-09-15$15.9B$33.60+9.6%+77.9%6.8Buy (14)$41.00 +22%
GCTGigaCloud Technology Inc.Leans down -3
medium
profitable 10.9%
revenue +11.1%
heavily indebted
—2022-08-18$2.4B$60.44+32.5%+435.4%5.0Buy (3)$73.67 +22%
ALMUAeluma, Inc.Leans down -3
weak
loss-making -205.3%
revenue -4.4%
heavily indebted
Large daily move2022-07-26$127M$5.40-63.2%—10.0Strong Buy (3)$18.00 +233%
HLNHaleon plcDown -4
medium
revenue -1.8%
liquidity 0.9
heavily indebted
Thin liquidity, Weakening confidence2022-07-18$40.1B$9.05-4.3%—3.0Buy (5)$10.40 +15%
IEIvanhoe Electric Inc.Mixed 0
medium
pre-revenue
revenue +11.8%
heavily indebted
Fell, analysts held2022-06-28$1.1B$5.76-36.3%-42.7%7.1Buy (7)$20.58 +257%
TOPTOP Financial Group LimitedMixed +1
weak
profitable 5.7%
revenue +41.9%
Large daily move, Weekly spike2022-06-01$2.1B$16.99+49.5%+178.7%———
ACDCProFrac Holding Corp.Down -9
strong
loss-making -20.4%
revenue -11.4%
liquidity 0.9
heavily indebted
Shrinking revenue, Thin liquidity, Value trap, Sell majority, Halved from offer2022-05-13$574M$2.95-40.3%-74.5%-3.8Sell (4)$5.16 +75%
BLCOBausch + Lomb CorporationMixed -1
medium
loss-making -2.0%
revenue +6.5%
heavily indebted
Downgrade2022-05-06$7.5B$20.69+24.1%+17.3%3.0Buy (15)$21.71 +5%
BLTEBelite Bio, IncLeans up +2
weak
——2022-04-29$6.6B$151.02+0.7%+16.5%8.9Strong Buy (9)$233.00 +54%
EEExcelerate Energy, Inc.Leans up +3
medium
profitable 3.5%
revenue +44.3%
heavily indebted
Improving confidence2022-04-13$4.3B$35.52+5.6%+48.8%7.3Buy (13)$43.92 +24%
DCDakota Gold Corp.Leans up +3
weak
——2022-04-05$715M$4.36-13.1%—9.2Strong Buy (6)$12.26 +181%
NVCTNuvectis Pharma, Inc.Leans up +2
weak
——2022-02-04$696M$19.84+6.1%+271.3%8.3Strong Buy (6)$35.40 +78%
CRDOCredo Technology Group Holding LtdLeans up +3
medium
profitable 33.8%
revenue +205.7%
—2022-01-27$24.7B$117.76-53.5%+2.1%8.3Strong Buy (20)$277.47 +136%
TPGTPG Inc.Leans up +2
medium
profitable 7.5%
revenue +27.0%
heavily indebted
—2022-01-13$18.6B$45.59-6.8%+69.5%5.9Buy (17)$59.53 +31%
AMLXAmylyx Pharmaceuticals, Inc.Mixed 0
medium
revenue -100.0%
Shrinking revenue2022-01-07$3.9B$26.20+41.3%+51.5%9.1Strong Buy (11)$43.00 +64%
ALLRAllarity Therapeutics, Inc.Mixed -1
weak
pre-revenue
heavily indebted
—2021-12-21$15M$0.87-28.8%————
IMMXImmix Biopharma, Inc.Leans up +3
weak
——2021-12-16$657M$7.04-30.9%+41.2%7.9Strong Buy (7)$23.80 +238%
IOTSamsara Inc.Mixed +1
medium
profitable 4.9%
revenue +29.6%
heavily indebted
—2021-12-15$24.2B$38.40+6.0%+83.9%7.3Buy (26)$52.07 +36%
SIDUSidus Space, Inc.Leans down -2
weak
pre-revenue
revenue -27.6%
Shrinking revenue2021-12-14$95M$0.80-62.9%-80.1%———
NRSNNeuroSense Therapeutics Ltd.Down -8
medium
liquidity 0.3
Thin liquidity, Downgrade, Monthly spike2021-12-09$3M$1.26-80.4%-76.0%3.3Buy (3)$91.75 +7182%
NUNu Holdings Ltd.Mixed +1
medium
profitable 27.1%
revenue +28.5%
heavily indebted
Large daily move2021-12-09$64.0B$11.82-10.3%+41.9%7.0Buy (23)$17.83 +51%
SGSweetgreen, Inc.Leans up +2
medium
profitable 2.8%
revenue +0.4%
heavily indebted
Profitable but deeply down, Improving confidence, Below target, Halved from offer2021-11-18$1.5B$12.18+108.5%-58.2%3.2Buy (14)$12.18 +0%
BRZEBraze, Inc.Down -4
medium
loss-making -13.6%
revenue +24.4%
heavily indebted
Under acquisition, Weakening confidence, Monthly spike2021-11-17$5.3B$46.24+66.9%-28.4%0.0Hold (19)$47.54 +3%
IRENIREN LimitedUp +4
strong
loss-making -194.4%
revenue +41.1%
heavily indebted
Fell on sound metrics, Improving confidence, Monthly spike2021-11-17$7.7B$14.41-59.5%-34.0%7.0Buy (20)$56.69 +293%
BLZEBackblaze, Inc.Leans up +2
weak
loss-making -11.5%
revenue +14.3%
heavily indebted
Fell, analysts held, Improving confidence, Large daily move, Halved from offer2021-11-11$489M$7.27-60.1%-56.7%7.1Buy (7)$21.50 +196%
CINTCI&T Inc.Leans up +2
medium
profitable 6.8%
revenue +11.6%
heavily indebted
Profitable but deeply down, Halved from offer2021-11-10$390M$2.87-13.3%-79.5%6.5Buy (10)$5.63 +96%
RIVNRivian Automotive, Inc.Up +5
weak
loss-making -45.9%
revenue +8.4%
heavily indebted
Fell, analysts held, Upgrade, Improving confidence, Halved from offer2021-11-10$17.8B$11.29-18.1%-84.9%3.2Buy (25)$17.94 +59%
TCBXThird Coast Bancshares, Inc.Leans up +3
medium
profitable 30.7%
revenue +21.9%
heavily indebted
Improving confidence2021-11-09$661M$37.60-13.3%+66.4%4.3Buy (7)$47.36 +26%
ARHSArhaus, Inc.Leans up +2
weak
profitable 4.5%
revenue +8.5%
heavily indebted
Improving confidence2021-11-04$1.9B$12.93+44.3%-6.5%4.7Buy (15)$14.15 +9%
CDRECadre Holdings, Inc.Mixed 0
medium
profitable 5.6%
revenue +7.5%
heavily indebted
—2021-11-04$1.4B$30.56+0.4%+148.5%8.3Strong Buy (6)$46.83 +53%
EVOEvotec SEMixed -1
weak
loss-making -25.2%
revenue -1.1%
heavily indebted
—2021-11-04$582M$1.45-19.4%-94.6%5.0Buy (3)$4.48 +209%
LIONLionsgate Studios Corp.Leans down -2
medium
loss-making -0.7%
revenue +1.8%
liquidity 0.4
Thin liquidity, Under acquisition2021-11-04$4.2B$13.47+17.4%-36.5%4.6Buy (12)$15.42 +14%
MDXHMDxHealth SADown -6
strong
loss-making -33.5%
revenue +19.8%
Weakening confidence, Junk zone, Monthly spike2021-11-04$14M$0.12-83.2%-98.9%1.7Hold (6)$0.83 +607%
NRDSNerdWallet, Inc.Down -4
strong
profitable 6.1%
revenue +21.7%
heavily indebted
Profitable but deeply down, Downgrade, Weakening confidence, Halved from offer2021-11-04$473M$7.02-22.3%-42.2%0.0Hold (5)$9.50 +35%
AURAAura Biosciences, Inc.Leans up +2
weak
heavily indebted
Fell, analysts held2021-10-29$740M$6.98-7.4%-53.3%9.2Strong Buy (6)$16.60 +138%
FLNCFluence Energy, Inc.Down -6
strong
loss-making -3.1%
revenue -16.1%
heavily indebted
Shrinking revenue, Sell majority, Halved from offer2021-10-28$864M$3.83-63.0%-83.5%0.2Hold (23)$7.95 +108%
GFSGLOBALFOUNDRIES Inc.Leans up +3
weak
profitable 2.8%
revenue +0.6%
heavily indebted
Improving confidence2021-10-28$23.1B$38.94-22.4%-4.5%4.8Buy (23)$64.77 +66%
AIPArteris, Inc.Leans up +3
weak
loss-making -44.8%
revenue +22.3%
heavily indebted
Improving confidence2021-10-27$962M$18.91-30.5%+38.5%10.0Strong Buy (7)$33.00 +75%
ARISAris Mining CorporationMixed +1
weak
profitable 23.7%
revenue +81.7%
heavily indebted
—2021-10-22$3.0B$12.74-18.5%————
COCOThe Vita Coco Company, Inc.Mixed +1
medium
profitable 15.7%
revenue +18.2%
heavily indebted
—2021-10-21$3.6B$65.18-3.6%+292.2%7.1Buy (12)$79.10 +21%
PTLOPortillo's Inc.Leans down -2
medium
profitable 2.2%
revenue +3.0%
liquidity 0.3
heavily indebted
Profitable but deeply down, Thin liquidity, Monthly spike, Halved from offer2021-10-21$517M$6.22+36.6%-73.5%2.5Hold (12)$7.22 +16%
RPCRidgepost Capital, IncDown -4
medium
profitable 10.8%
revenue +0.3%
liquidity 0.8
heavily indebted
Thin liquidity, Weakening confidence2021-10-21$1.0B$9.30+11.7%—5.0Buy (4)$13.00 +40%
GTLBGitLab Inc.Leans up +2
weak
loss-making -5.0%
revenue +25.8%
—2021-10-14$8.0B$43.68+17.8%-32.8%2.9Buy (28)$56.29 +29%
IHSIHS Holding LimitedMixed 0
weak
loss-making -1.1%
revenue +3.6%
Halved from offer2021-10-14$2.8B$8.43+1.1%-59.6%3.8Buy (4)$8.00 -5%
LTHLife Time Group Holdings, Inc.Mixed -1
weak
profitable 12.7%
revenue +14.3%
liquidity 0.7
heavily indebted
Thin liquidity2021-10-07$10.4B$46.54+2.6%+140.3%9.0Strong Buy (15)$57.60 +24%
FWRGFirst Watch Restaurant Group, Inc.Leans up +2
medium
profitable 1.4%
revenue +20.3%
liquidity 0.2
heavily indebted
Fell on sound metrics, Thin liquidity, Improving confidence2021-10-01$814M$11.61+7.1%-26.3%10.0Strong Buy (10)$18.90 +63%
WRBYWarby Parker Inc.Mixed +1
weak
profitable 0.8%
revenue +13.0%
heavily indebted
—2021-09-29$3.4B$24.13+7.2%-35.8%6.9Buy (13)$32.25 +34%
AMPLAmplitude, Inc.Mixed -1
medium
loss-making -25.2%
revenue +14.7%
heavily indebted
Halved from offer2021-09-28$2.2B$16.54+37.5%-50.2%5.9Buy (11)$21.27 +29%
RELYRemitly Global, Inc.Up +5
strong
profitable 19.1%
revenue +29.4%
heavily indebted
Fell on sound metrics, Profitable but deeply down, Halved from offer2021-09-23$4.8B$20.06-14.3%-40.5%9.0Strong Buy (10)$32.00 +60%
FRSHFreshworks Inc.Mixed 0
medium
profitable 22.3%
revenue +16.4%
heavily indebted
Profitable but deeply down, Downgrade, Halved from offer2021-09-22$3.3B$12.29+2.8%-58.7%4.1Buy (17)$16.69 +36%
TOSTToast, Inc.Mixed -1
weak
profitable 7.7%
revenue +24.1%
Downgrade2021-09-22$20.1B$31.85+1.1%-16.4%5.7Buy (31)$38.89 +22%
VBNKVersaBankLeans up +2
medium
profitable 22.8%
revenue +11.7%
heavily indebted
—2021-09-22$774M$22.21+19.1%+125.2%6.7Buy (3)$27.50 +24%
ACTEnact Holdings, Inc.Down -5
strong
profitable 54.1%
revenue +2.8%
heavily indebted
Weakening confidence, Sell majority2021-09-16$6.1B$44.19-8.8%+147.8%-1.7Hold (6)$47.00 +6%
BROSDutch Bros Inc.Leans up +2
medium
profitable 5.1%
revenue +27.9%
heavily indebted
—2021-09-15$6.4B$34.15-28.8%+102.8%8.5Strong Buy (27)$55.04 +61%
ONONOn Holding AGLeans up +2
medium
profitable 13.1%
revenue +30.0%
heavily indebted
—2021-09-15$11.2B$30.82+7.4%+33.2%6.6Buy (32)$43.87 +42%
PRCTPROCEPT BioRobotics CorporationDown -5
strong
loss-making -32.6%
revenue +37.2%
heavily indebted
Weakening confidence, Below target2021-09-15$1.4B$25.75+12.8%-10.2%2.3Hold (15)$22.75 -12%
TYRATyra Biosciences, Inc.Leans up +2
weak
——2021-09-15$1.4B$19.73-23.6%+26.2%8.7Strong Buy (15)$47.45 +140%
SRADSportradar Group AGMixed -1
medium
profitable 1.5%
revenue +16.6%
liquidity 0.8
heavily indebted
Profitable but deeply down, Thin liquidity, Halved from offer2021-09-14$3.8B$12.02-2.4%-54.9%6.5Buy (23)$17.41 +45%
DDIDoubleDown Interactive Co., Ltd.Down -5
strong
profitable 32.9%
revenue +5.5%
heavily indebted
Downgrade, Weakening confidence2021-08-31$781M$15.35+26.6%-13.0%0.0Hold (5)$16.25 +6%
RZLVRezolve AI PLCDown -4
medium
revenue +2224.2%
liquidity 0.5
heavily indebted
Thin liquidity, Halved from offer2021-08-13$500M$0.93-54.0%—8.8Strong Buy (4)$10.00 +974%
CLYMClimb Bio, Inc.Leans up +3
weak
——2021-08-10$609M$9.28-40.6%-21.6%9.4Strong Buy (16)$28.40 +206%
DOLEDole plcLeans up +2
weak
profitable 1.0%
revenue +8.2%
heavily indebted
Improving confidence2021-07-30$1.3B$12.54+10.8%-14.2%6.0Buy (5)$17.55 +40%
HTZHertz Global Holdings, Inc.Down -4
weak
loss-making -3.8%
revenue -6.0%
liquidity 0.8
Thin liquidity, Sell majority2021-07-30$536M$1.23-30.6%—-2.2Hold (9)$2.02 +64%
HOODRobinhood Markets, Inc.Leans up +3
medium
profitable 39.0%
revenue +51.6%
heavily indebted
Improving confidence2021-07-29$70.1B$68.65-19.1%+112.3%6.4Buy (32)$127.77 +86%
RSKDRiskified Ltd.Mixed 0
weak
loss-making -4.2%
revenue +5.2%
heavily indebted
Halved from offer2021-07-29$1.2B$9.63+47.1%-56.2%3.3Buy (6)$11.20 +16%
DUOLDuolingo, Inc.Mixed 0
medium
profitable 12.3%
revenue +38.7%
heavily indebted
Improving confidence, Below target2021-07-28$7.8B$149.38+27.0%+36.7%1.9Hold (24)$153.93 +3%
CADLCandel Therapeutics, Inc.Leans up +2
weak
heavily indebted
Fell, analysts held, Improving confidence, Large daily move, Weekly spike2021-07-27$486M$5.13-49.0%-28.1%10.0Strong Buy (10)$17.67 +244%
CNMCore & Main, Inc.Mixed -1
medium
profitable 6.0%
revenue +2.8%
heavily indebted
—2021-07-23$8.6B$41.67-0.8%+121.0%4.3Buy (15)$54.29 +30%
CRBUCaribou Biosciences, Inc.Down -7
strong
pre-revenue
revenue +11.7%
heavily indebted
Weakening confidence, Junk zone, Halved from offer2021-07-23$39M$0.31-76.9%-97.8%2.0Hold (5)$5.00 +1510%
CTKBCytek Biosciences, Inc.Mixed +1
weak
loss-making -39.1%
revenue +0.5%
heavily indebted
Halved from offer2021-07-23$764M$6.32+23.2%-66.0%5.0Buy (3)$6.50 +3%
SOPHSOPHiA GENETICS SAMixed 0
weak
loss-making -89.2%
revenue +18.6%
heavily indebted
Halved from offer2021-07-23$703M$6.68+7.6%-54.6%10.0Strong Buy (5)$9.75 +46%
USCBUSCB Financial Holdings, Inc.Mixed 0
medium
profitable 29.6%
revenue +9.1%
heavily indebted
—2021-07-23$373M$19.50-10.0%+106.7%3.0Buy (5)$23.25 +19%
ABSIAbsci CorporationMixed +1
weak
pre-revenue
revenue -38.2%
Fell, analysts held, Shrinking revenue, Large daily move, Halved from offer2021-07-22$1.5B$8.16-8.6%-49.7%8.3Strong Buy (12)$15.09 +85%
GXOGXO Logistics, Inc.Mixed -1
weak
profitable 1.0%
revenue +12.6%
liquidity 0.8
heavily indebted
Thin liquidity2021-07-22$6.2B$53.87+15.4%—8.8Strong Buy (17)$71.06 +32%
RYANRyan Specialty Holdings, Inc.Leans down -2
medium
profitable 3.2%
revenue +21.3%
heavily indebted
Weakening confidence2021-07-22$11.8B$46.62+12.5%+90.1%3.4Buy (19)$49.28 +6%
LAWCS Disco, Inc.Mixed +1
weak
loss-making -18.5%
revenue +8.3%
heavily indebted
Monthly spike, Halved from offer2021-07-21$432M$5.73+53.7%-81.3%5.0Buy (3)$8.00 +40%
VTEXVTEXMixed 0
medium
profitable 10.5%
revenue +6.1%
heavily indebted
Profitable but deeply down, Weakening confidence, Halved from offer2021-07-21$643M$3.24+11.9%-79.1%3.0Buy (10)$5.51 +70%
ERASErasca, Inc.Mixed +1
weak
heavily indebted
—2021-07-16$5.5B$14.22-14.3%-4.6%6.7Buy (9)$24.11 +70%
RGCRegencell Bioscience Holdings LimitedMixed -1
weak
heavily indebted
Monthly spike2021-07-16$2.5B$4.36-7.7%-37.9%———
STVNStevanato Group S.p.A.Leans down -2
medium
profitable 11.2%
revenue +7.5%
heavily indebted
Downgrade, Large daily move2021-07-16$4.3B$15.93-25.7%+9.4%5.8Buy (13)$19.46 +22%
TCRXTScan Therapeutics, Inc.Down -6
strong
pre-revenue
revenue +266.6%
heavily indebted
Weakening confidence, Junk zone2021-07-16$11M$0.14-79.5%-99.0%2.0Hold (5)$1.00 +601%
PECOPhillips Edison & Company, Inc.Mixed -1
weak
profitable 23.9%
revenue +9.9%
liquidity 0.8
heavily indebted
Thin liquidity2021-07-15$5.8B$40.39+3.1%+43.9%5.0Buy (14)$43.46 +8%
SGHTSight Sciences, Inc.Leans up +2
weak
loss-making -32.1%
revenue -3.1%
heavily indebted
Improving confidence, Halved from offer2021-07-15$602M$10.62+31.4%-59.0%6.9Buy (8)$12.25 +15%
MRTMarti Technologies, Inc.Up +4
medium
loss-making -51.2%
revenue +110.3%
Halved from offer2021-07-09$181M$2.03+14.1%—8.0Strong Buy (5)$5.04 +148%
DNUTKrispy Kreme, Inc.Down -5
medium
loss-making -5.9%
revenue -8.6%
liquidity 0.4
heavily indebted
Thin liquidity, Sell majority, Halved from offer2021-07-01$680M$3.41+22.5%-81.3%0.7Hold (7)$4.52 +33%
EVCMEverCommerce Inc.Down -5
strong
profitable 4.8%
revenue +4.8%
heavily indebted
Profitable but deeply down, Downgrade, Weakening confidence, Sell majority, Large daily move, Weekly spike, Halved from offer2021-07-01$1.1B$6.00-37.7%-61.0%0.6Hold (8)$8.25 +38%
HEPSD-Market Elektronik Hizmetler ve Ticaret A.S.Mixed -1
weak
loss-making -8.6%
revenue +13.4%
liquidity 1.0
heavily indebted
Thin liquidity, Halved from offer2021-07-01$1.2B$2.62+1.1%-76.7%5.0Buy (2)$3.35 +28%
INTAIntapp, Inc.Down -5
strong
loss-making -4.7%
revenue +14.6%
liquidity 0.7
heavily indebted
Thin liquidity, Below target2021-06-30$3.5B$42.43+19.9%+82.8%3.3Buy (9)$43.00 +1%
LZLegalZoom.com, Inc.Down -5
strong
profitable 2.6%
revenue +10.9%
liquidity 0.7
heavily indebted
Profitable but deeply down, Thin liquidity, Downgrade, Halved from offer2021-06-30$824M$4.56-8.3%-76.4%0.7Hold (7)$6.38 +40%
SSentinelOne, Inc.Mixed 0
weak
loss-making -30.9%
revenue +21.9%
Halved from offer2021-06-30$7.7B$24.01+1.7%-32.5%4.9Buy (34)$24.92 +4%
XMTRXometry, Inc.Mixed 0
medium
loss-making -2.0%
revenue +25.9%
heavily indebted
—2021-06-30$6.9B$111.39+33.3%+125.8%6.3Buy (12)$125.55 +13%
YOUClear Secure, Inc.Leans down -2
medium
profitable 16.2%
revenue +16.9%
liquidity 1.0
heavily indebted
Thin liquidity2021-06-30$7.5B$54.94+30.5%+58.5%3.3Buy (6)$69.67 +27%
GHRSGH Research PLCLeans up +3
weak
——2021-06-25$1.3B$18.56-36.3%+31.5%8.5Strong Buy (10)$42.89 +131%
TKNOAlpha Teknova, Inc.Leans up +2
weak
loss-making -34.8%
revenue +7.3%
heavily indebted
Improving confidence, Halved from offer2021-06-25$516M$7.81+13.7%-54.0%8.8Strong Buy (8)$9.83 +26%
DOCSDoximity, Inc.Down -4
weak
profitable 21.1%
revenue +13.1%
Weakening confidence, Below target2021-06-24$5.9B$29.61+36.0%+29.6%1.9Hold (21)$31.50 +6%
GLUEMonte Rosa Therapeutics, Inc.Up +4
strong
loss-making -186.2%
revenue +63.5%
heavily indebted
Fell on sound metrics, Halved from offer2021-06-24$801M$8.91-39.1%-50.4%9.0Strong Buy (10)$25.38 +185%
CXMSprinklr, Inc.Mixed 0
medium
profitable 2.6%
revenue +7.6%
heavily indebted
Profitable but deeply down, Halved from offer2021-06-23$1.6B$6.52+1.5%-56.1%2.2Hold (9)$8.44 +29%
FAFirst Advantage CorporationLeans up +2
medium
profitable 2.5%
revenue +83.0%
heavily indebted
—2021-06-23$3.7B$21.16+5.8%+34.3%4.5Buy (10)$27.75 +31%
YMMFull Truck Alliance Co. Ltd.Up +6
strong
profitable 33.0%
revenue +11.1%
Fell on sound metrics, Profitable but deeply down, Halved from offer2021-06-22$9.0B$9.06-1.7%-56.5%7.3Buy (15)$12.51 +38%
BRBIBRBI BR Partners S.A.Leans down -2
weak
profitable 1.4%
revenue +67.6%
liquidity 0.3
heavily indebted
Thin liquidity, Monthly spike, Halved from offer2021-06-21$194M$7.62-12.4%————
FEMYFemasys Inc.Mixed 0
weak
pre-revenue
revenue +40.8%
heavily indebted
—2021-06-18$12M$1.26-34.3%—7.5Buy (2)$16.50 +1210%
AOMRAngel Oak Mortgage REIT, Inc.Mixed +1
weak
loss-making -86.3%
revenue +18.5%
heavily indebted
Halved from offer2021-06-17$138M$5.47-34.1%—6.7Buy (6)$9.15 +67%
IPSCCentury Therapeutics, Inc.Leans up +3
medium
revenue +1556.8%
heavily indebted
Halved from offer2021-06-17$300M$1.32-15.4%—7.0Buy (5)$4.75 +260%
LYELLyell Immunopharma, Inc.Leans up +2
weak
pre-revenue
revenue -41.0%
heavily indebted
Shrinking revenue, Improving confidence, Large daily move, Monthly spike, Halved from offer2021-06-17$352M$13.58+5.5%—6.9Buy (8)$37.63 +177%
BZKanzhun LimitedMixed +1
medium
profitable 52.9%
revenue +12.4%
Weekly spike, Halved from offer2021-06-11$5.8B$13.13-16.7%—8.2Strong Buy (22)$20.74 +58%
JANXJanux Therapeutics, Inc.Leans down -3
medium
pre-revenue
revenue -5.5%
heavily indebted
Downgrade, Weekly spike, Halved from offer2021-06-11$696M$10.29-30.1%—7.5Buy (18)$33.14 +222%
TASKTaskUs, Inc.Down -4
medium
profitable 8.2%
revenue +18.9%
heavily indebted
Below target, Halved from offer2021-06-11$845M$8.71+28.1%—1.3Hold (8)$9.17 +5%
DIBS1stdibs.Com, Inc.Mixed -1
weak
loss-making -6.0%
revenue +1.5%
heavily indebted
Halved from offer2021-06-10$195M$5.51+15.6%————
LFSTLifeStance Health Group, Inc.Mixed -1
medium
profitable 4.3%
revenue +13.8%
heavily indebted
—2021-06-10$5.4B$13.34+12.2%—7.3Buy (11)$16.80 +26%
MNDYmonday.com Ltd.Mixed 0
medium
profitable 10.1%
revenue +26.8%
heavily indebted
Weakening confidence, Halved from offer2021-06-10$3.3B$69.90-6.4%—3.9Buy (26)$100.93 +44%
ZETAZeta Global Holdings Corp.Mixed +1
medium
profitable 2.3%
revenue +29.7%
heavily indebted
—2021-06-10$9.4B$32.22+27.1%—8.0Strong Buy (15)$40.14 +25%
MQMarqeta, Inc.Mixed 0
weak
profitable 18.8%
revenue +23.2%
Halved from offer2021-06-09$1.9B$16.43+17.5%—0.7Hold (14)$20.78 +26%
DLODLocal LimitedUp +5
medium
profitable 15.0%
revenue +46.6%
Improving confidence, Halved from offer2021-06-03$3.9B$12.67-1.6%—7.5Buy (10)$18.50 +46%
FIGSFIGS, Inc.Mixed +1
weak
profitable 9.7%
revenue +13.6%
heavily indebted
—2021-05-27$3.7B$20.32+54.0%—5.5Buy (10)$23.22 +14%
FLYWFlywire CorporationLeans up +2
medium
profitable 10.3%
revenue +26.6%
—2021-05-26$2.7B$21.40+21.6%—4.3Buy (15)$23.39 +9%
PAYPaymentus Holdings, Inc.Mixed 0
medium
profitable 6.7%
revenue +37.2%
Weakening confidence2021-05-26$4.3B$32.16-15.4%—4.3Buy (7)$41.17 +28%
ZIPZipRecruiter, Inc.Leans down -3
weak
profitable 9.3%
revenue -5.3%
Below target, Weekly spike, Halved from offer2021-05-26$450M$5.89+13.4%—2.0Hold (5)$5.25 -11%
OTLYOatly Group ABDown -4
strong
loss-making -9.5%
revenue +4.7%
liquidity 0.4
Thin liquidity, Weakening confidence2021-05-20$244M$7.17-43.9%—4.0Buy (5)$14.50 +102%
PCORProcore Technologies, Inc.Mixed +1
weak
loss-making -2.3%
revenue +14.8%
heavily indebted
—2021-05-20$11.6B$73.30+33.0%—7.2Buy (25)$86.27 +18%
VERAVera Therapeutics, Inc.Mixed +1
weak
pre-revenue
heavily indebted
—2021-05-14$2.0B$26.75-11.2%—8.2Strong Buy (14)$71.36 +167%
GLBEGlobal-E Online Ltd.Leans up +3
medium
profitable 13.9%
revenue +27.8%
heavily indebted
—2021-05-12$7.0B$35.10+1.3%—8.1Strong Buy (13)$51.38 +46%
SMWBSimilarweb Ltd.Mixed 0
medium
loss-making -7.4%
revenue +13.1%
liquidity 0.8
heavily indebted
Thin liquidity, Improving confidence, Halved from offer2021-05-12$703M$7.88-6.9%—5.0Buy (8)$10.83 +37%
WDHWaterdrop Inc.Leans up +3
medium
profitable 10.7%
revenue +43.5%
heavily indebted
Improving confidence, Halved from offer2021-05-07$363M$1.01+1.0%—8.8Strong Buy (4)$1.73 +71%
AURAurora Innovation, Inc.Leans up +2
medium
pre-revenue
revenue +200.0%
heavily indebted
Halved from offer2021-05-06$8.5B$3.84-39.6%—5.4Buy (13)$11.55 +201%
BWMNBowman Consulting Group Ltd.Down -8
strong
loss-making -0.2%
revenue +14.9%
liquidity 0.9
heavily indebted
Thin liquidity, Under acquisition, Weakening confidence, Below target2021-05-06$745M$43.00+54.6%—1.0Hold (5)$43.00 +0%
FSBCFive Star BancorpLeans up +2
medium
profitable 41.3%
revenue +25.7%
heavily indebted
—2021-05-05$1.1B$41.87-5.4%—5.0Buy (5)$51.40 +23%
HNSTThe Honest Company, Inc.Leans down -2
medium
profitable 23.5%
revenue -1.9%
heavily indebted
Downgrade, Halved from offer2021-05-05$547M$4.48+6.7%—3.6Buy (7)$5.22 +17%
HOWLWerewolf Therapeutics, Inc.Leans down -2
weak
loss-making -164.8%
revenue -100.0%
Shrinking revenue, Halved from offer2021-04-30$48M$0.99+141.4%————
AVAHAveanna Healthcare Holdings Inc.Leans up +3
medium
profitable 11.4%
revenue +20.2%
heavily indebted
Improving confidence2021-04-29$2.5B$10.70-9.4%—6.4Buy (11)$15.20 +42%
PRVAPrivia Health Group, Inc.Mixed +1
weak
profitable 1.4%
revenue +22.3%
—2021-04-29$3.1B$24.69+14.2%—8.1Strong Buy (18)$31.35 +27%
FTCIFTC Solar, Inc.Mixed -1
medium
loss-making -22.2%
revenue +110.5%
liquidity 0.9
Thin liquidity, Large daily move, Weekly spike2021-04-28$19M$0.81-54.7%—10.0Strong Buy (3)$10.20 +1161%
SWIMLatham Group, Inc.Down -4
medium
profitable 1.6%
revenue +7.3%
heavily indebted
Weakening confidence, Halved from offer2021-04-23$973M$7.97+15.8%—2.1Hold (7)$8.80 +10%
TMCITreace Medical Concepts, Inc.Up +4
weak
loss-making -27.4%
revenue +1.6%
heavily indebted
Upgrade, Improving confidence, Weekly spike, Halved from offer2021-04-23$345M$4.35+17.1%—3.0Buy (5)$6.17 +42%
NPCENeuroPace, Inc.Down -4
strong
loss-making -19.3%
revenue +25.1%
heavily indebted
Downgrade, Weakening confidence, Large daily move, Weekly spike, Monthly spike, Halved from offer2021-04-22$260M$8.14-47.1%—6.0Buy (10)$14.11 +73%
DVDoubleVerify Holdings, Inc.Down -4
medium
profitable 8.2%
revenue +13.9%
heavily indebted
Weakening confidence, Halved from offer2021-04-21$2.1B$13.56+1.9%—0.0Hold (14)$13.64 +1%
PATHUiPath, Inc.Leans down -2
medium
profitable 21.0%
revenue +12.7%
heavily indebted
Halved from offer2021-04-21$6.9B$11.23-17.0%—0.8Hold (20)$15.41 +37%
DNAGinkgo Bioworks Holdings, Inc.Down -7
medium
loss-making -249.2%
revenue -25.1%
heavily indebted
Shrinking revenue, Sell majority, Halved from offer2021-04-19$623M$8.20+38.9%—-5.0Sell (3)$8.00 -2%
BMEABiomea Fusion, Inc.Mixed 0
medium
heavily indebted
Halved from offer2021-04-16$42M$0.59-56.9%—6.7Buy (6)$6.17 +949%
RXRXRecursion Pharmaceuticals, Inc.Mixed +1
medium
pre-revenue
revenue +27.0%
heavily indebted
Halved from offer2021-04-16$2.0B$2.72+2.4%—2.9Buy (7)$6.82 +151%
AGLagilon health, inc.Leans up +2
weak
loss-making -1.4%
revenue -2.1%
heavily indebted
Improving confidence, Halved from offer2021-04-15$1.9B$89.50+19.4%—3.0Buy (15)$122.33 +37%
APPAppLovin CorporationMixed +1
medium
profitable 65.9%
revenue +70.0%
heavily indebted
Monthly spike2021-04-15$135.5B$379.02+31.1%—7.0Buy (32)$453.28 +20%
COINCoinbase Global, Inc.Mixed +1
weak
loss-making -12.5%
revenue +9.4%
heavily indebted
Halved from offer2021-04-15$33.8B$108.87-15.2%—5.1Buy (37)$195.00 +79%
ALKTAlkami Technology, Inc.Down -5
strong
loss-making -7.2%
revenue +32.9%
heavily indebted
Downgrade, Weakening confidence, Halved from offer2021-04-14$1.5B$12.64-30.8%—1.1Hold (9)$16.17 +28%
COMPCompass, Inc.Mixed 0
weak
profitable 1.1%
revenue +23.7%
heavily indebted
Halved from offer2021-04-01$7.8B$9.97-17.6%—5.8Buy (12)$12.46 +25%
KAROKarooooo Ltd.Leans down -2
medium
profitable 17.6%
revenue +20.0%
liquidity 0.6
heavily indebted
Thin liquidity2021-04-01$2.0B$60.68+1.9%—6.7Buy (6)$74.41 +23%
COURCoursera, Inc.Mixed 0
weak
loss-making -14.4%
revenue +9.0%
Halved from offer2021-03-31$889M$3.45-36.6%—3.6Buy (11)$5.88 +70%
ALHCAlignment Healthcare, Inc.Mixed 0
medium
profitable 0.6%
revenue +46.1%
heavily indebted
Weakening confidence, Halved from offer2021-03-26$1.5B$6.50-45.3%—5.0Buy (15)$10.79 +66%
DSGNDesign Therapeutics, Inc.Leans up +3
weak
—Halved from offer2021-03-26$670M$9.32-30.7%—8.8Strong Buy (8)$21.57 +131%
EWTXEdgewise Therapeutics, Inc.Leans up +2
weak
——2021-03-26$5.0B$41.17+4.3%—8.1Strong Buy (13)$55.42 +35%
TDUPThredUp Inc.Down -5
strong
loss-making -6.9%
revenue +19.5%
heavily indebted
Downgrade, Weakening confidence, Weekly spike, Halved from offer2021-03-26$210M$1.55-44.8%—5.7Buy (7)$2.80 +81%
ZHZhihu Inc.Mixed -1
weak
loss-making -11.4%
revenue -23.6%
heavily indebted
Shrinking revenue, Halved from offer2021-03-26$203M$2.42-16.6%—7.5Buy (6)$4.09 +69%
CRCTCricut, Inc.Leans down -2
medium
profitable 13.4%
revenue -0.5%
heavily indebted
Sell majority, Halved from offer2021-03-25$1.8B$8.30+57.0%—-8.3Strong Sell (3)$4.73 -43%
DOCNDigitalOcean Holdings, Inc.Mixed +1
weak
profitable 3.1%
revenue +15.5%
heavily indebted
Improving confidence2021-03-24$10.2B$77.09-36.2%—7.7Strong Buy (17)$159.93 +107%
CNTBConnect Biopharma Holdings LimitedLeans down -3
medium
pre-revenue
revenue -99.8%
heavily indebted
Shrinking revenue, Halved from offer2021-03-19$43M$0.63-72.8%—9.3Strong Buy (7)$6.00 +855%
TILInstil Bio, Inc.Mixed -1
weak
heavily indebted
—2021-03-19$41M$5.55-17.4%————
GANXGain Therapeutics, Inc.Mixed 0
medium
heavily indebted
Halved from offer2021-03-18$45M$1.05-49.0%—9.0Strong Buy (5)$6.60 +529%
TUYATuya Inc.Mixed +1
weak
profitable 20.2%
revenue +7.8%
Halved from offer2021-03-18$999M$1.54-8.4%—8.8Strong Buy (4)$3.17 +106%
HAYWHayward Holdings, Inc.Mixed +1
medium
profitable 14.3%
revenue +6.7%
heavily indebted
Monthly spike2021-03-12$3.4B$16.11+11.4%—3.0Buy (10)$17.50 +9%
CPNGCoupang, Inc.Mixed -1
weak
loss-making -3.8%
revenue +14.1%
liquidity 0.8
heavily indebted
Thin liquidity, Halved from offer2021-03-11$27.2B$14.06-3.4%—6.5Buy (17)$22.53 +60%
RBLXRoblox CorporationDown -4
strong
loss-making -16.5%
revenue +35.8%
liquidity 0.8
Thin liquidity, Downgrade, Weakening confidence2021-03-10$35.7B$46.35+31.6%—3.1Buy (35)$50.30 +9%
BETRBetter Home & Finance Holding CompanyUp +4
strong
loss-making -76.1%
revenue +72.3%
heavily indebted
Improving confidence, Monthly spike, Halved from offer2021-03-04$294M$15.61+14.0%—5.6Buy (8)$24.00 +54%
INNVInnovAge Holding Corp.Mixed +1
weak
profitable 0.9%
revenue +15.9%
heavily indebted
Halved from offer2021-03-04$1.3B$8.91-11.2%—1.7Hold (3)$12.00 +35%
OSCROscar Health, Inc.Mixed +1
medium
profitable 4.9%
revenue +27.5%
heavily indebted
Improving confidence2021-03-03$9.6B$26.17-1.6%—0.9Hold (11)$37.00 +41%
SPWRSunPower Inc.Leans down -3
weak
loss-making -5.8%
revenue +175.9%
liquidity 0.8
Thin liquidity, Large daily move, Weekly spike2021-02-26$33M$3.80-26.6%—10.0Strong Buy (2)$1.45 +806%
SOCSable Offshore Corp.Leans down -2
medium
loss-making -202.5%
liquidity 0.3
heavily indebted
Thin liquidity, Large daily move, Weekly spike, Monthly spike, Halved from offer2021-02-25$152M$0.55-81.8%—7.9Strong Buy (7)$9.60 +1640%
LGVNLongeveron Inc.Mixed -1
weak
pre-revenue
revenue -49.9%
heavily indebted
Shrinking revenue, Large daily move, Weekly spike, Monthly spike2021-02-12$8M$1.82-69.6%———$61.25 +3265%
AENTAlliance Entertainment Holding CorporationMixed -1
weak
profitable 1.1%
revenue +8.0%
heavily indebted
Halved from offer2021-02-11$252M$4.78-9.5%—8.3Strong Buy (3)$9.00 +88%
AFCGAdvanced Flower Capital Inc.Leans down -2
weak
profitable 65.3%
revenue -46.0%
heavily indebted
Shrinking revenue, Halved from offer2021-02-11$74M$3.30-4.3%————
BMBLBumble Inc.Down -4
medium
loss-making -61.8%
revenue -9.9%
heavily indebted
Under acquisition, Below target, Halved from offer2021-02-11$928M$5.99+130.4%—0.0Hold (8)$3.84 -36%
BVSBioventus Inc.Mixed +1
weak
profitable 9.8%
revenue -0.9%
heavily indebted
—2021-02-11$898M$9.95-23.2%—8.0Strong Buy (5)$16.60 +67%
LDIloanDepot, Inc.Leans down -3
weak
loss-making -9.0%
revenue +20.6%
heavily indebted
Sell majority, Weekly spike, Halved from offer2021-02-11$153M$0.42-48.5%—-3.8Sell (4)$0.50 +18%
DSPViant Technology Inc.Mixed +1
weak
profitable 1.9%
revenue +19.0%
heavily indebted
Halved from offer2021-02-10$781M$11.00-5.5%—8.6Strong Buy (11)$19.32 +76%
PIIIP3 Health Partners Inc.Leans down -3
weak
loss-making -3.3%
revenue -2.8%
liquidity 0.5
heavily indebted
Thin liquidity, Weekly spike2021-02-10$20M$1.86-74.5%—5.0Buy (2)$12.25 +559%
ADAGAdagene Inc.Leans up +3
medium
revenue +7332.8%
heavily indebted
Improving confidence, Large daily move, Halved from offer2021-02-09$115M$2.01-55.4%—10.0Strong Buy (6)$9.91 +393%
BOLTBolt Biotherapeutics, Inc.Mixed +1
weak
pre-revenue
revenue +0.1%
heavily indebted
Monthly spike2021-02-05$12M$5.06+90.0%—6.7Buy (3)$41.00 +710%
ELTXElicio Therapeutics, Inc.Leans down -3
weak
heavily indebted
—2021-02-05$42M$1.50-50.3%—6.7Buy (3)$13.00 +767%
EVAXEvaxion A/SMixed -1
medium
loss-making -115.6%
revenue +125.1%
heavily indebted
—2021-02-05$25M$2.03-12.5%—8.8Strong Buy (4)$12.25 +503%
IMCRImmunocore Holdings plcMixed +1
medium
loss-making -7.5%
revenue +28.9%
heavily indebted
—2021-02-05$1.5B$26.63-14.6%—5.8Buy (12)$59.40 +123%
PHVSPharvaris N.V.Leans up +3
weak
——2021-02-05$2.3B$31.66-5.5%—8.9Strong Buy (14)$58.16 +84%
VORVor Biopharma Inc.Leans up +3
weak
—Halved from offer2021-02-05$1.2B$18.52-15.6%—8.5Strong Buy (10)$39.00 +111%
SANASana Biotechnology, Inc.Leans up +2
weak
heavily indebted
Halved from offer2021-02-04$605M$1.74-45.1%—7.8Strong Buy (9)$8.57 +393%
CGNTCognyte Software Ltd.Mixed +1
weak
loss-making -0.0%
revenue +14.1%
heavily indebted
Improving confidence, Halved from offer2021-02-02$608M$7.78-7.9%—5.0Buy (4)$12.33 +58%
TRINTrinity Capital Inc.Mixed +1
medium
profitable 67.4%
revenue +16.6%
heavily indebted
—2021-01-29$1.7B$16.91-1.2%—6.1Buy (9)$19.00 +12%
VINPVinci Compass Investments Ltd.Leans up +3
medium
profitable 25.7%
revenue +62.7%
heavily indebted
Halved from offer2021-01-28$577M$8.22-6.7%—7.5Buy (6)$12.63 +54%
ZIMZIM Integrated Shipping Services Ltd.Mixed -1
weak
profitable 2.1%
revenue -18.1%
heavily indebted
Shrinking revenue, Under acquisition, Improving confidence2021-01-28$3.5B$29.62+1.8%—1.3Hold (4)$29.18 -1%
SHLSShoals Technologies Group, Inc.Mixed -1
medium
profitable 5.8%
revenue +19.1%
heavily indebted
Under acquisition, Halved from offer2021-01-27$1.4B$7.19+0.7%—5.0Buy (14)$11.39 +58%
MNTKMontauk Renewables, Inc.Down -5
weak
profitable 4.2%
revenue +0.4%
liquidity 0.6
heavily indebted
Thin liquidity, Large daily move, Weekly spike, Monthly spike, Halved from offer2021-01-22$137M$1.15-49.0%—0.0Hold (2)$1.55 +35%
PAXPatria Investments LimitedMixed 0
medium
profitable 16.4%
revenue +2.0%
heavily indebted
Halved from offer2021-01-22$1.5B$9.05-19.7%—3.3Buy (6)$14.83 +64%
RLXRLX Technology Inc.Up +4
medium
profitable 21.9%
revenue +48.0%
Halved from offer2021-01-22$1.9B$1.46-16.6%—8.3Strong Buy (6)$2.78 +90%
DFHDream Finders Homes, Inc.Mixed -1
weak
profitable 2.6%
revenue -2.9%
heavily indebted
—2021-01-20$965M$9.93-29.3%————
DRVNDriven Brands Holdings Inc.Down -6
medium
profitable 9.9%
revenue +6.3%
heavily indebted
Downgrade, Weakening confidence, Halved from offer2021-01-15$1.9B$10.83-11.2%—1.9Hold (13)$14.83 +37%
PDYNPalladyne AI Corp.Leans down -3
medium
loss-making -196.7%
revenue -32.6%
heavily indebted
Shrinking revenue, Improving confidence, Halved from offer2021-01-15$159M$2.71-52.2%—7.5Buy (4)$7.63 +182%
PLTKPlaytika Holding Corp.Mixed -1
weak
loss-making -9.8%
revenue +8.1%
Halved from offer2021-01-15$1.0B$2.51+16.8%—1.8Hold (11)$4.24 +69%
WOOFPetco Health and Wellness Company, Inc.Down -6
medium
profitable 0.5%
revenue -2.5%
liquidity 0.9
heavily indebted
Thin liquidity, Sell majority, Halved from offer2021-01-14$815M$2.48+5.4%—0.4Hold (12)$3.47 +40%
AFRMAffirm Holdings, Inc.Leans up +3
medium
profitable 43.9%
revenue +32.1%
heavily indebted
—2021-01-13$22.1B$56.91-12.6%—7.2Buy (36)$95.81 +68%
CGEMCullinan Therapeutics, Inc.Mixed +1
weak
—Halved from offer2021-01-08$667M$9.07-50.1%—9.6Strong Buy (12)$34.70 +283%
GBCGeorgia Banking Company, Inc.Mixed 0
weak
revenue +42.7%
heavily indebted
——$382M$33.94—————
NARANarragansett Bancorp, Inc.Mixed -1
weak
profitable 5.3%
revenue +12.0%
heavily indebted
——$224M$10.14—————
PCTPureCycle Technologies, Inc.Mixed -1
medium
pre-revenue
revenue -3.3%
heavily indebted
Monthly spike, Halved from offer—$343M$1.75-76.4%—4.0Buy (5)$6.40 +266%

Showing 470 of 470 tracked IPOs. Our balance, the flags, the fundamentals and the analyst figures come from the weekly run of 2026-11-16. Prices are refreshed daily and were last taken on 2026-11-19; a thinly traded company shows its most recent trade, which may be older. Use the filters to narrow the list, or click a column heading to sort.

Every IPO we track, in one table, with what we make of it set against what the market and the analysts make of it. The left-hand columns are ours: the balance of arguments for and against each company, what its filings say about profit, growth and debt, and the signals our model raised this week. The right-hand columns are the things you can look up elsewhere — price, market cap, the analyst consensus and its target. Put side by side, they show you where the two disagree.

Two words on this site mean different things, and it is worth getting them straight. Ratings are what the sell-side analysts say — their recommendations, their target prices, their upgrades and downgrades. Scores are what we say. This page is about the second, and about what happens when the two disagree.

For the mechanics of scoring an individual company, see the Method page. For the rules the simulated fund follows, see Portfolio Rules.

Where a score shows up

  1. In a company analysis. Every company piece ends with an evaluation and a verdict, built from the factors set out on the Method page, with each row visible so the total can be checked against it.
  2. In the Model Portfolio. A simulated fund that acts on the score mechanically, following a published rule set on notional capital. Every move it makes names the rule that produced it.
  3. In the Ratings column, where the score is set against the analyst consensus on the same company, and the article is about the gap between them.
Read the column: all Ratings articles →

How we set our view against theirs

1. Label pieces

Short articles about listed companies, each built on one of six descriptive labels. The labels describe where a share price sits relative to what the analysts who cover that company expect — and where those analysts disagree with each other. Every label requires the numbers that justify it: how many analysts cover the company, what the consensus is, the consensus target price, where the share price actually is, and the gap between the two as a percentage. No numbers, no label.

Confirmed
Our score and the analyst consensus point the same way, and the price sits near the consensus target. No tension.
Overextended
The price is above the consensus target. The market has run ahead of the people who follow the company most closely.
Dislocated
The price is well below the consensus target while the consensus is still favourable and not deteriorating. One of the two is wrong, and that is the article.
Crowded
Unusually many analysts cover it and almost all of them are positive. Little room left for upgrades, plenty for downgrades.
Orphaned
Meaningful market capitalisation, barely any coverage — often four or five analysts. Thin information, wide dispersion in both directions.
Diverging
Recent analyst moves contradict each other, or the recommendation index is falling while the headline consensus is still favourable. The strongest signal, because the professionals themselves do not agree.

Each label is a description, never a recommendation. A label says where the disagreement is; it does not say what to do about it.

2. Screen pieces

Longer articles about a field rather than a company, each built on a computation we run on our own data:

  1. Access. Which private companies can actually be reached from a public market, which require accredited status, and which cannot be reached at all. Where a listed vehicle exists, its premium or discount to net asset value — measured only between a NAV and a price of the same date.
  2. Mark divergence. Where independent fund families disagree about what a private company is worth. Funds holding private positions must report them to the SEC on Form N-PORT each quarter, which yields a dated price per share. We compare those marks, and a dispersion above 10% is a story in itself.
  3. Model versus market. Where our own score and the share price point in different directions. Two standing screens run this test on every listed IPO we track, and are rebuilt each week: where the price fell while the rating held, and where the price rose while the rating stayed cautious.
  4. Cohort results. How a whole field actually performed against expectations — a quarter's listings, a sector, a year's intake — and the two or three cases that explain the aggregate.
  5. Thin markets. How much supply a lock-up expiry releases against the stock's own trading volume. The measure is defined, and the whole table kept, on Key Dates.

What every piece contains

A computation of our own, named and explained. A section on what the numbers do not tell you. A thirty-second checklist so you can run the same screen yourself. A methodology note listing every figure, its source and its date. And sources you can open.

No investment advice, ever. We name companies and give numbers, and we describe the mechanism — holders sitting on a profit have a reason to sell; a thin market has no room to absorb supply; coverage is not conviction. We do not give buy, sell, long or short calls, entry levels, stop losses, target prices or position sizes. The conclusion is yours. The one exception is our Model Portfolio, a simulated fund running a published rule set on notional capital, which is labelled as such wherever it appears.

Where the data comes from

SEC filings are our first tier and are enough on their own: S-1, F-1, 424B4, 8-K, 10-Q, 10-K and N-PORT, together with company releases, exchange notices and regulatory decisions. Established financial press — Reuters, Bloomberg, the Wall Street Journal, the Financial Times, CNBC, Nikkei, the South China Morning Post — is used only with attribution, naming the publication and the date in the text. Aggregators, blogs, social media and anonymous rumour never carry a claim. Analyst coverage, consensus and target prices are an input to the labels above, held in our own dataset. Listing dates and lock-up expiries are on Calendar and Key Dates.

This page replaced a published table of analyst consensus data on 13 November 2026. The table was retired because a raw list of sell-side ratings adds little on its own: those ratings are built largely from past results and regularly diverge from what a share price goes on to do. The underlying data is still collected and still used — as an input to the labels described above, rather than as a page of its own.

On 14 November 2026 the page moved from /analyst-ratings/ to /scores/, and the article section kept the name Ratings. The old address redirects here. The two names now mean what they say: Ratings is what the analysts said, Scores is what we think.

iposight.com — for informational purposes only, not investment advice.

What the filters mean

Our balance

For every company we collect what argues for it and what argues against it, drawn from the filings, the price history and the analyst data. The number is the difference: +6 means six more arguments for than against. Under it sits the confidence — weak where most of the arguments come from a single source, strong where the company numbers, the analysts and the price all point the same way. Only 20 of the 470 companies earn a strong reading. The balance gives a direction, not a price, and it is not advice.

Diverges from the street

This returns the companies where our balance points the opposite way to the analysts: the consensus is a buy but our balance leans down, or the consensus is hold or sell but our balance leans up. We only apply it where at least three analysts cover the company, because nothing meaningfully diverges from one or two opinions. It is the most useful filter on the page. It does not tell you who is right; it tells you where it is worth looking.

Analyst index

This one is not ours. It is an index computed from how the analysts are split between buy, hold and sell. A company nobody covers has no index at all — 33 of the 470 are in that position. It sits on this page because it is what we measure our own balance against.

Fundamentals

Four things from the filings: whether the company is profitable and at what net margin, whether revenue is growing, whether short-term liabilities are covered, and how leveraged it is. Liquidity and debt only appear when there is a problem — a current ratio below 1, or debt to equity above 2. An empty cell means the figure is not published; for recent listings and pre-revenue companies that is the normal case.

Flags

Twenty-one events we recompute every week, from lock-up expiries and rating changes to a price that has halved from the offer. With several selected the default is all of them, which narrows the list; switching to any of them widens it. A flag with no companies this week still appears, because it fires in other weeks.

Where the numbers come from

Prices, market caps, analyst ratings and targets are market data. The balance, the flags and the way the fundamentals are read here are ours, computed weekly from company filings and price history. The table is rebuilt every Monday evening and the as-of date is shown above it. Nothing on this page is a recommendation to buy or sell.